ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
GO:0035329,hippo signaling,13/81,54/13083,0.24074074074074073,38.8840877914952,22.017736665960587,6.493012894734999e-18,1.6037741849995448e-14,1.0477672386977637e-14,NF2/AMOTL2/NUAK2/LATS2/SCHIP1/TEAD1/AMOTL1/AMOT/WWC2/FRMD6/WWTR1/YAP1/STK3,13
GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,19/81,304/13083,0.0625,10.094907407407407,12.663715339894926,2.135230586094264e-14,2.6370097738264163e-11,1.722793941306583e-11,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/ITGB5/SMAD7/UBE2D1/SMAD2/SMAD3/USP9X/RUNX2/WWTR1/SMAD6/SMAD1,19
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,18/81,285/13083,0.06315789473684211,10.201169590643275,12.395638822590788,9.504879320097454e-14,7.3083161282967e-11,4.7746211909988675e-11,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/ITGB5/SMAD7/UBE2D1/SMAD2/SMAD3/USP9X/RUNX2/SMAD6/SMAD1,18
GO:0045667,regulation of osteoblast differentiation,13/81,110/13083,0.11818181818181818,19.08855218855219,15.036766013907268,1.1835329762423806e-13,7.3083161282967e-11,4.7746211909988675e-11,CRIM1/CCN1/JAG1/FGF2/TP63/SMAD3/RUNX2/GSK3B/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,13
GO:0048729,tissue morphogenesis,21/81,481/13083,0.04365904365904366,7.051744051744053,10.673524554554477,8.562038622320612e-13,4.2296470794263824e-10,2.7632853069510524e-10,NF2/CCN1/MYC/INHBA/JAG1/TGFB2/FGF2/SLIT2/DLC1/TGM2/ITGB5/SMAD7/SMAD2/TP63/SMAD3/FAT1/EGFR/CTNNB1/YAP1/SMAD1/STK3,21
GO:0001503,ossification,18/81,349/13083,0.05157593123209169,8.330468003820439,10.955608244671733,2.995489639482468e-12,1.2331432349202827e-9,8.056290556713375e-10,RUNX1/CRIM1/IGFBP3/CCN2/CCN1/JAG1/FGF2/SMAD7/TP63/SMAD3/RUNX2/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,18
GO:0072073,kidney epithelium development,12/81,117/13083,0.10256410256410256,16.566001899335234,13.348777749380515,6.206480158244059e-12,2.1900008558375467e-9,1.4307570049004727e-9,MYC/JAG1/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,12
GO:0040008,regulation of growth,20/81,485/13083,0.041237113402061855,6.660557464681175,10.026601899994308,9.392020728234472e-12,2.777729733708093e-9,1.8147281831555538e-9,RUNX1/IGFBP3/CDK1/LATS2/DAB2/INHBA/TGFB2/FGF2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/GSK3B/WWC2/EGFR/CREB1/SMARCA2/YAP1/STK3,20
GO:0007507,heart development,20/81,487/13083,0.04106776180698152,6.633204045935052,9.999496624901807,1.0121282430515318e-11,2.777729733708093e-9,1.8147281831555538e-9,RUNX1/CDK1/CCN1/INHBA/JAG1/BICC1/TGFB2/FGF2/SLIT2/DLC1/SMAD7/SMAD2/SMAD3/EGFR/CTNNB1/CREB1/YAP1/SMAD6/SMAD1/STK3,20
GO:1902895,positive regulation of miRNA transcription,9/81,48/13083,0.1875,30.28472222222222,16.042820003143774,1.1679364660843482e-11,2.88480307122834e-9,1.884680634218217e-9,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0001649,osteoblast differentiation,14/81,197/13083,0.07106598984771574,11.478473397255124,11.696247932193389,1.459564410622748e-11,3.277385540216534e-9,2.141160039698252e-9,CRIM1/IGFBP3/CCN1/JAG1/FGF2/TP63/SMAD3/RUNX2/GSK3B/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,14
GO:0060395,SMAD protein signal transduction,10/81,72/13083,0.1388888888888889,22.433127572016463,14.393650717321014,1.8361991014496154e-11,3.779509817150458e-9,2.469204581159878e-9,DAB2/INHBA/TGFB2/SMAD7/SMAD2/SMAD3/RUNX2/WWTR1/SMAD6/SMAD1,10
GO:0001822,kidney development,15/81,255/13083,0.058823529411764705,9.501089324618738,10.820309792844403,3.816687522482286e-11,7.251706292716343e-9,4.7376372242634376e-9,CENPF/MYC/JAG1/BICC1/TGFB2/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,15
GO:2000630,positive regulation of miRNA metabolic process,9/81,55/13083,0.16363636363636364,26.430303030303033,14.916554049176412,4.2765121729829396e-11,7.544989333762757e-9,4.929242978332969e-9,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0072001,renal system development,15/81,260/13083,0.057692307692307696,9.318376068376068,10.693131422173366,5.027138328713039e-11,8.278021114614137e-9,5.408142496783922e-9,CENPF/MYC/JAG1/BICC1/TGFB2/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/WWTR1/YAP1/SMAD6/SMAD1,15
GO:0090287,regulation of cellular response to growth factor stimulus,15/81,265/13083,0.05660377358490566,9.142557651991615,10.569346760535108,6.582719541492575e-11,1.0162073292179162e-8,6.6390191165184984e-9,TET1/CRIM1/LATS2/CCN1/FSTL1/FGF2/SLIT2/THBS1/SMAD7/UBE2D1/SMAD2/SMAD3/RUNX2/CTNNB1/SMAD6,15
GO:0045669,positive regulation of osteoblast differentiation,9/81,60/13083,0.15,24.227777777777774,14.233190705254472,9.698613769307026e-11,1.3430263882602037e-8,8.774171971885329e-9,CCN1/JAG1/FGF2/TP63/RUNX2/CTNNB1/WWTR1/YAP1/SMAD1,9
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,14/81,227/13083,0.06167400881057269,9.961494534181758,10.750160342176063,9.787236837523751e-11,1.3430263882602037e-8,8.774171971885329e-9,TET1/CRIM1/LATS2/DAB2/CCN1/INHBA/FSTL1/TGFB2/THBS1/SMAD7/UBE2D1/SMAD2/SMAD3/SMAD6,14
GO:0001525,angiogenesis,18/81,433/13083,0.04157043879907621,6.714395688991532,9.544287124004287,1.0708263283047043e-10,1.3920742267961156e-8,9.094608095795632e-9,RUNX1/AMOTL2/CCN2/CCN1/ETS1/JAG1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/SLIT2/THBS1/TGM2/AMOTL1/AMOT/CTNNB1/SMAD1,18
GO:1902893,regulation of miRNA transcription,9/81,66/13083,0.13636363636363635,22.025252525252526,13.515503737313175,2.3569516128277786e-10,2.9108352418423067e-8,1.9016878012973605e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0061614,miRNA transcription,9/81,67/13083,0.13432835820895522,21.69651741293532,13.405110725341045,2.7091770319052e-10,3.186508223240878e-8,2.0817886666218907e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0048598,embryonic morphogenesis,18/81,485/13083,0.03711340206185567,5.994501718213058,8.846810712517069,6.714986012830716e-10,7.539097932587212e-8,4.9253940467318135e-8,NF2/LATS2/CCN1/INHBA/ETS2/TGFB2/FGF2/DLC1/ITGB5/SMAD2/TP63/SMAD3/RUNX2/AMOT/CTNNB1/YAP1/SMAD1/STK3,18
GO:0001657,ureteric bud development,9/81,75/13083,0.12,19.38222222222222,12.600793095612875,7.647430138530453e-10,8.212674974856617e-8,5.3654509850650736e-8,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0072163,mesonephric epithelium development,9/81,76/13083,0.11842105263157894,19.12719298245614,12.509019953754443,8.631651572901915e-10,8.528071754027093e-8,5.571503941582585e-8,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0072164,mesonephric tubule development,9/81,76/13083,0.11842105263157894,19.12719298245614,12.509019953754443,8.631651572901915e-10,8.528071754027093e-8,5.571503941582585e-8,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0001823,mesonephros development,9/81,77/13083,0.11688311688311688,18.87878787878788,12.418983798112059,9.725574667788781e-10,9.026498396965477e-8,5.897132769038175e-8,MYC/FGF2/SLIT2/SMAD7/SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0007179,transforming growth factor beta receptor signaling pathway,12/81,180/13083,0.06666666666666667,10.767901234567901,10.415177232072594,9.867022539193031e-10,9.026498396965477e-8,5.897132769038175e-8,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:2000628,regulation of miRNA metabolic process,9/81,78/13083,0.11538461538461539,18.636752136752136,12.330629127625558,1.0939571441645135e-9,9.650264807451244e-8,6.304647751895486e-8,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0002009,morphogenesis of an epithelium,16/81,401/13083,0.0399002493765586,6.444629167821188,8.74019492211475,2.446677424668784e-9,2.0838942203213436e-7,1.3614361132548988e-7,CCN1/MYC/JAG1/TGFB2/FGF2/SLIT2/DLC1/TGM2/ITGB5/TP63/SMAD3/FAT1/EGFR/CTNNB1/YAP1/STK3,16
GO:0030509,BMP signaling pathway,10/81,123/13083,0.08130081300813008,13.13158687142427,10.669453337408093,3.988782629246046e-9,3.2840976980792445e-7,2.145545182678663e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0071772,response to BMP,10/81,129/13083,0.07751937984496124,12.520815389032443,10.378883263909923,6.346486464833335e-9,4.89869424004323e-7,3.200382812693916e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0071773,cellular response to BMP stimulus,10/81,129/13083,0.07751937984496124,12.520815389032443,10.378883263909923,6.346486464833335e-9,4.89869424004323e-7,3.200382812693916e-7,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/USP9X/RUNX2/SMAD6/SMAD1,10
GO:0010586,miRNA metabolic process,9/81,96/13083,0.09375,15.14236111111111,10.97684721989237,7.111355446802536e-9,5.322741804121897e-7,3.4774187878622927e-7,ETS1/MYC/TGFB2/FGF2/TEAD1/SMAD3/EGFR/SMAD6/SMAD1,9
GO:0010717,regulation of epithelial to mesenchymal transition,9/81,99/13083,0.09090909090909091,14.683501683501685,10.786612934294507,9.353772016534468e-9,6.795240259070627e-7,4.4394218270425196e-7,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0043065,positive regulation of apoptotic process,16/81,442/13083,0.03619909502262444,5.8468241997653765,8.18186270553813,9.81667460007873e-9,6.927767503484131e-7,4.526003657720509e-7,IGFBP3/LATS2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/SLIT2/THBS1/DLC1/TGM2/TP63/GSK3B/CTNNB1/STK3,16
GO:0045765,regulation of angiogenesis,12/81,224/13083,0.05357142857142857,8.652777777777779,9.118302889968833,1.181350358197261e-8,7.886311850668202e-7,5.152233567898724e-7,RUNX1/ETS1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/THBS1/TGM2/AMOT/CTNNB1/SMAD1,12
GO:0071560,cellular response to transforming growth factor beta stimulus,12/81,224/13083,0.05357142857142857,8.652777777777779,9.118302889968833,1.181350358197261e-8,7.886311850668202e-7,5.152233567898724e-7,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:0035265,organ growth,10/81,140/13083,0.07142857142857142,11.537037037037036,9.893262895316433,1.4018127493447708e-8,9.111782870741011e-7,5.952850262453003e-7,RUNX1/CDK1/LATS2/TGFB2/FGF2/SMAD2/WWC2/YAP1/SMAD1/STK3,10
GO:0043068,positive regulation of programmed cell death,16/81,455/13083,0.035164835164835165,5.67977207977208,8.019321310658215,1.4781441137991302e-8,9.338138943930921e-7,6.100731728551505e-7,IGFBP3/LATS2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/SLIT2/THBS1/DLC1/TGM2/TP63/GSK3B/CTNNB1/STK3,16
GO:0071559,response to transforming growth factor beta,12/81,229/13083,0.05240174672489083,8.463852498786995,8.993653318047548,1.512249221689218e-8,9.338138943930921e-7,6.100731728551505e-7,TET1/LATS2/DAB2/TGFB2/THBS1/ITGB5/SMAD7/SMAD2/SMAD3/USP9X/SMAD6/SMAD1,12
GO:1901342,regulation of vasculature development,12/81,230/13083,0.05217391304347826,8.427053140096618,8.969179104959373,1.58765100078201e-8,9.422990333156449e-7,6.156166282006749e-7,RUNX1/ETS1/GADD45A/SERPINE1/TGFB2/DDAH1/FGF2/THBS1/TGM2/AMOT/CTNNB1/SMAD1,12
GO:0016049,cell growth,15/81,395/13083,0.0379746835443038,6.133614627285514,8.177107882499884,1.6022898542209346e-8,9.422990333156449e-7,6.156166282006749e-7,IGFBP3/DAB2/INHBA/TGFB2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/USP9X/GSK3B/EGFR/CTNNB1/SMARCA2/YAP1,15
GO:0050678,regulation of epithelial cell proliferation,13/81,285/13083,0.0456140350877193,7.367511371020144,8.578188933086219,1.8907553535709084e-8,1.0860850519349172e-6,7.095539674477852e-7,DAB2/MYC/JAG1/TGFB2/FGF2/THBS1/TP63/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,13
GO:0050673,epithelial cell proliferation,14/81,344/13083,0.040697674418604654,6.573428079242033,8.268152051859673,2.1498990642281737e-8,1.2068751565099066e-6,7.884677668568877e-7,IGFBP3/DAB2/MYC/JAG1/TGFB2/FGF2/THBS1/TP63/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,14
GO:0003184,pulmonary valve morphogenesis,5/81,15/13083,0.3333333333333333,53.839506172839506,16.161226529389115,2.2964777648311556e-8,1.2476563951778793e-6,8.151106984051519e-7,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0030336,negative regulation of cell migration,12/81,238/13083,0.05042016806722689,8.143790849673202,8.778587783993215,2.3235706145013135e-8,1.2476563951778793e-6,8.151106984051519e-7,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B,12
GO:0010718,positive regulation of epithelial to mesenchymal transition,7/81,52/13083,0.1346153846153846,21.742877492877493,11.829225282679166,2.863026710417575e-8,1.5046119095173212e-6,9.829831908331786e-7,DAB2/JAG1/TGFB2/SMAD2/SMAD3/CTNNB1/WWTR1,7
GO:0031589,cell-substrate adhesion,13/81,300/13083,0.043333333333333335,6.999135802469136,8.296738978071838,3.4706242626505204e-8,1.7859254018222471e-6,1.1667690777726422e-6,NF2/CCN2/DAB2/CCN1/JAG1/SERPINE1/THBS1/DLC1/ITGB5/SMAD3/GSK3B/CTNNB1/SMAD6,13
GO:2000146,negative regulation of cell motility,12/81,248/13083,0.04838709677419355,7.815412186379928,8.552528525387164,3.666573818596086e-8,1.8465680342329037e-6,1.206387724900508e-6,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B,12
GO:0001501,skeletal system development,15/81,421/13083,0.035629453681710214,5.75481657429401,7.827050974300755,3.737991972131384e-8,1.8465680342329037e-6,1.206387724900508e-6,RUNX1/CCN2/CCN1/ETS2/TGFB2/FGF2/TGM2/HEXB/SMAD7/SMAD2/TP63/SMAD3/RUNX2/CTNNB1/SMAD1,15
GO:0043408,regulation of MAPK cascade,16/81,489/13083,0.032719836400818,5.284859501628418,7.622258482181114,4.0513318227689e-8,1.962115608282193e-6,1.281876508628426e-6,NF2/IGFBP3/CCN2/DAB2/CCN1/MYC/INHBA/GADD45B/GADD45A/TGFB2/FGF2/THBS1/TAOK1/EGFR/CTNNB1/STK3,16
GO:0003007,heart morphogenesis,11/81,203/13083,0.054187192118226604,8.752234993614305,8.786006443790644,4.4950785559133024e-8,2.1351623140588186e-6,1.3949302482216787e-6,CCN1/JAG1/TGFB2/SLIT2/DLC1/SMAD7/SMAD2/SMAD3/CTNNB1/YAP1/SMAD6,11
GO:0061035,regulation of cartilage development,7/81,57/13083,0.12280701754385964,19.83560753736192,11.248277569203571,5.519310054655125e-8,2.572206761320407e-6,1.6804572619237948e-6,CCN2/CCN1/SMAD7/SMAD3/RUNX2/CTNNB1/SMAD1,7
GO:0040013,negative regulation of locomotion,12/81,263/13083,0.045627376425855515,7.3696662441909595,8.23616501951252,6.99810694050996e-8,3.2009859524184447e-6,2.0912471617547308e-6,TET1/NF2/IGFBP3/JAG1/GADD45A/SERPINE1/FGF2/SLIT2/THBS1/DLC1/SMAD7/GSK3B,12
GO:0003177,pulmonary valve development,5/81,19/13083,0.2631578947368421,42.50487329434697,14.289344542060817,8.721396719880337e-8,3.916699981473533e-6,2.5588327601103457e-6,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0033002,muscle cell proliferation,10/81,171/13083,0.05847953216374269,9.445527398743772,8.77409985555466,9.43800937250397e-8,4.162836276800858e-6,2.7196369112873283e-6,RUNX1/IGFBP3/CDK1/TGFB2/FGF2/THBS1/EGFR/CTNNB1/YAP1/SMAD1,10
GO:0060828,regulation of canonical Wnt signaling pathway,11/81,219/13083,0.0502283105022831,8.112802300016911,8.378172161931328,9.764243617911895e-8,4.231172234428488e-6,2.7642817112204867e-6,LATS2/DAB2/BICC1/FGF2/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,11
GO:0001558,regulation of cell growth,13/81,331/13083,0.03927492447129909,6.343627615530939,7.772049025595015,1.0974626723926507e-7,4.605411873815201e-6,3.0087774994923092e-6,IGFBP3/DAB2/INHBA/TGFB2/SLIT2/SGK1/SMAD7/TEAD1/SMAD3/GSK3B/EGFR/SMARCA2/YAP1,13
GO:0035330,regulation of hippo signaling,6/81,38/13083,0.15789473684210525,25.502923976608184,11.938841049302916,1.1000781398991774e-7,4.605411873815201e-6,3.0087774994923092e-6,NF2/NUAK2/SCHIP1/WWC2/FRMD6/STK3,6
GO:0007498,mesoderm development,8/81,96/13083,0.08333333333333333,13.459876543209877,9.670956647124532,1.2957848027708437e-7,5.334314104739973e-6,3.484979127452112e-6,NF2/INHBA/ETS2/SMAD2/TP63/SMAD3/YAP1/SMAD1,8
GO:0060038,cardiac muscle cell proliferation,6/81,41/13083,0.14634146341463414,23.636856368563684,11.458042971237564,1.7654624269061116e-7,7.148675728619829e-6,4.67032597143584e-6,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0001704,formation of primary germ layer,8/81,101/13083,0.07920792079207921,12.793546021268794,9.39093407078439,1.9263521748761227e-7,7.552523606260355e-6,4.9341652198581395e-6,NF2/INHBA/ETS2/ITGB5/SMAD2/SMAD3/CTNNB1/SMAD1,8
GO:0002065,columnar/cuboidal epithelial cell differentiation,8/81,101/13083,0.07920792079207921,12.793546021268794,9.39093407078439,1.9263521748761227e-7,7.552523606260355e-6,4.9341652198581395e-6,JAG1/SERPINE1/FGF2/SMAD2/TP63/GSK3B/CTNNB1/YAP1,8
GO:0007160,cell-matrix adhesion,10/81,195/13083,0.05128205128205128,8.283000949667617,8.087409047450624,3.221242434058678e-7,1.2431982518945211e-5,8.121981334559135e-6,NF2/CCN2/JAG1/SERPINE1/THBS1/DLC1/ITGB5/SMAD3/GSK3B/CTNNB1,10
GO:0046620,regulation of organ growth,7/81,74/13083,0.0945945945945946,15.278778778778777,9.722086238933274,3.4529987720307295e-7,1.3121395333716772e-5,8.57238399598884e-6,RUNX1/CDK1/LATS2/FGF2/WWC2/YAP1/STK3,7
GO:0001837,epithelial to mesenchymal transition,9/81,152/13083,0.05921052631578947,9.56359649122807,8.381783418173859,3.8912966894443946e-7,1.45628830650419e-5,9.51412731246931e-6,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0061036,positive regulation of cartilage development,5/81,26/13083,0.19230769230769232,31.06125356125356,12.110067384863354,4.769092649919522e-7,1.7581580366121223e-5,1.1486282847331702e-5,CCN1/SMAD7/SMAD3/RUNX2/SMAD1,5
GO:0060485,mesenchyme development,11/81,258/13083,0.04263565891472868,6.886448463967844,7.5371821891221105,5.076827155747267e-7,1.8324578388514915e-5,1.197169344538392e-5,DAB2/MYC/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1/YAP1,11
GO:0007369,gastrulation,9/81,157/13083,0.05732484076433121,9.259023354564757,8.217144904985942,5.119011776548701e-7,1.8324578388514915e-5,1.197169344538392e-5,NF2/INHBA/ETS2/ITGB5/SMAD2/SMAD3/AMOT/CTNNB1/SMAD1,9
GO:0016055,Wnt signaling pathway,13/81,388/13083,0.03350515463917526,5.4117029400534555,6.9627415182120185,6.778534187948851e-7,2.3907673881575446e-5,1.561920479883024e-5,AMOTL2/LATS2/DAB2/BICC1/FGF2/AMOTL1/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,13
GO:0060070,canonical Wnt signaling pathway,11/81,266/13083,0.041353383458646614,6.679337231968811,7.386178253825465,6.872246338428569e-7,2.3907673881575446e-5,1.561920479883024e-5,LATS2/DAB2/BICC1/FGF2/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,11
GO:0001953,negative regulation of cell-matrix adhesion,5/81,28/13083,0.17857142857142858,28.84259259259259,11.640583519637973,7.056629553105109e-7,2.420815971690225e-5,1.5815516235248732e-5,NF2/JAG1/SERPINE1/THBS1/DLC1,5
GO:0003179,heart valve morphogenesis,6/81,52/13083,0.11538461538461539,18.636752136752136,10.057867542825312,7.572420341082892e-7,2.543057374279605e-5,1.6614135754402874e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD2/SMAD6,6
GO:0030510,regulation of BMP signaling pathway,7/81,83/13083,0.08433734939759036,13.622043730477465,9.104823924578081,7.618876343995577e-7,2.543057374279605e-5,1.6614135754402874e-5,CRIM1/CCN1/FSTL1/SMAD7/UBE2D1/SMAD2/SMAD6,7
GO:0051216,cartilage development,9/81,167/13083,0.05389221556886228,8.704590818363274,7.908940297720102,8.611686647630457e-7,2.836115469286297e-5,1.8528723692375425e-5,RUNX1/CCN2/CCN1/FGF2/SMAD7/SMAD3/RUNX2/CTNNB1/SMAD1,9
GO:0043410,positive regulation of MAPK cascade,12/81,334/13083,0.03592814371257485,5.803060545575515,7.018232235491183,9.16150603221349e-7,2.977489460469384e-5,1.9452338985295403e-5,IGFBP3/CCN2/INHBA/GADD45B/GADD45A/TGFB2/FGF2/THBS1/TAOK1/EGFR/CTNNB1/STK3,12
GO:0090288,negative regulation of cellular response to growth factor stimulus,7/81,86/13083,0.08139534883720931,13.146856158484066,8.920024676097997,9.714371877266167e-7,3.116168641149017e-5,2.0358348718864024e-5,CRIM1/FGF2/SLIT2/THBS1/SMAD7/UBE2D1/SMAD6,7
GO:0030111,regulation of Wnt signaling pathway,11/81,279/13083,0.03942652329749104,6.368113633346607,7.153613471560391,1.0998286089686902e-6,3.482790595067519e-5,2.2753539238178165e-5,LATS2/DAB2/BICC1/FGF2/SMAD3/GSK3B/EGFR/CTNNB1/WWTR1/YAP1/STK3,11
GO:0060411,cardiac septum morphogenesis,6/81,56/13083,0.10714285714285714,17.305555555555557,9.651213175383084,1.184144873785451e-6,3.7023263775317263e-5,2.418779602282607e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0042476,odontogenesis,7/81,90/13083,0.07777777777777778,12.56255144032922,8.68749793471592,1.3242465227267438e-6,4.088611138918822e-5,2.6711446307106556e-5,NF2/INHBA/SERPINE1/TGFB2/TP63/RUNX2/CTNNB1,7
GO:0045766,positive regulation of angiogenesis,8/81,131/13083,0.061068702290076333,9.863726321741588,8.047445962982117,1.4201622746115577e-6,4.330618294185861e-5,2.8292511591676648e-5,RUNX1/ETS1/SERPINE1/DDAH1/FGF2/THBS1/TGM2/SMAD1,8
GO:1904888,cranial skeletal system development,6/81,58/13083,0.10344827586206896,16.7088122605364,9.463308129954683,1.4617132739107663e-6,4.402965593365357e-5,2.87651662247138e-5,TGFB2/SMAD2/TP63/SMAD3/RUNX2/CTNNB1,6
GO:0048546,digestive tract morphogenesis,5/81,33/13083,0.15151515151515152,24.47250280583614,10.655789060836005,1.6633144592795447e-6,4.94986351134997e-5,3.2338123856379736e-5,SMAD2/TP63/SMAD3/EGFR/CTNNB1,5
GO:1904018,positive regulation of vasculature development,8/81,134/13083,0.05970149253731343,9.642896627971254,7.937214250646717,1.685319094891293e-6,4.95564067188273e-5,3.237586682291168e-5,RUNX1/ETS1/SERPINE1/DDAH1/FGF2/THBS1/TGM2/SMAD1,8
GO:0014855,striated muscle cell proliferation,6/81,61/13083,0.09836065573770492,15.887067395264115,9.198345697613338,1.9758578021804655e-6,5.741610319277353e-5,3.751071220733937e-5,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0010810,regulation of cell-substrate adhesion,9/81,185/13083,0.04864864864864865,7.857657657657659,7.414382374674854,2.021437340542813e-6,5.755864170344168e-5,3.7603834532868577e-5,NF2/DAB2/CCN1/JAG1/SERPINE1/THBS1/DLC1/SMAD3/GSK3B,9
GO:0048565,digestive tract development,7/81,96/13083,0.07291666666666667,11.777391975308644,8.365066074356696,2.050672255021404e-6,5.755864170344168e-5,3.7603834532868577e-5,TGFB2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/YAP1,7
GO:0072089,stem cell proliferation,7/81,96/13083,0.07291666666666667,11.777391975308644,8.365066074356696,2.050672255021404e-6,5.755864170344168e-5,3.7603834532868577e-5,RUNX1/NF2/FGF2/TP63/RUNX2/CTNNB1/YAP1,7
GO:0060563,neuroepithelial cell differentiation,5/81,35/13083,0.14285714285714285,23.074074074074073,10.320935042783226,2.2531736155215305e-6,6.253189697009191e-5,4.085292906675939e-5,JAG1/SERPINE1/FGF2/SMAD2/CTNNB1,5
GO:0003170,heart valve development,6/81,63/13083,0.09523809523809523,15.382716049382717,9.031922243928703,2.3941644620272985e-6,6.498446396931239e-5,4.2455224063480036e-5,CCN1/JAG1/TGFB2/SLIT2/SMAD2/SMAD6,6
GO:0055017,cardiac muscle tissue growth,6/81,63/13083,0.09523809523809523,15.382716049382717,9.031922243928703,2.3941644620272985e-6,6.498446396931239e-5,4.2455224063480036e-5,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0032924,activin receptor signaling pathway,5/81,37/13083,0.13513513513513514,21.826826826826828,10.012897763939977,2.996266649866961e-6,8.044324592577603e-5,5.255465416757496e-5,INHBA/SMAD7/SMAD2/SMAD3/SMAD6,5
GO:0014706,striated muscle tissue development,11/81,311/13083,0.03536977491961415,5.71287364534953,6.639127924264008,3.162719414740021e-6,8.399910703664357e-5,5.4877746041838736e-5,RUNX1/CDK1/CENPF/TGFB2/FGF2/SMAD7/SMAD3/CTNNB1/CREB1/YAP1/SMAD1,11
GO:0055123,digestive system development,7/81,103/13083,0.06796116504854369,10.976986695433297,8.02333933061841,3.292611993782743e-6,8.651863430471676e-5,5.652378708251899e-5,TGFB2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/YAP1,7
GO:0001952,regulation of cell-matrix adhesion,7/81,104/13083,0.0673076923076923,10.871438746438747,7.977209713968488,3.512767925713259e-6,9.133196606854474e-5,5.966840144175541e-5,NF2/JAG1/SERPINE1/THBS1/DLC1/SMAD3/GSK3B,7
GO:0048638,regulation of developmental growth,10/81,255/13083,0.0392156862745098,6.334059549745824,6.78926836053666,3.6957510553537555e-6,9.5088594861706e-5,6.212265754229504e-5,RUNX1/CDK1/LATS2/FGF2/SMAD7/GSK3B/WWC2/CREB1/YAP1/STK3,10
GO:0072091,regulation of stem cell proliferation,6/81,68/13083,0.08823529411764706,14.251633986928105,8.647215915753401,3.763103379556697e-6,9.582335409799011e-5,6.26026856306068e-5,NF2/FGF2/TP63/RUNX2/CTNNB1/YAP1,6
GO:0060419,heart growth,6/81,69/13083,0.08695652173913043,14.045088566827697,8.575129297661105,4.10128325526308e-6,1.0232616661564337e-4,6.685106048232744e-5,RUNX1/CDK1/TGFB2/FGF2/YAP1/SMAD1,6
GO:0008544,epidermis development,10/81,258/13083,0.03875968992248062,6.260407694516221,6.735581127623232,4.101332184189755e-6,1.0232616661564337e-4,6.685106048232744e-5,CCN2/LATS2/INHBA/JAG1/TGFB2/FGF2/TP63/EGFR/CTNNB1/YAP1,10
GO:1905314,semi-lunar valve development,5/81,40/13083,0.125,20.189814814814813,9.593708825480311,4.457782593532851e-6,1.1010723006026142e-4,7.193453385143012e-5,JAG1/TGFB2/SLIT2/SMAD2/SMAD6,5
GO:0032330,regulation of chondrocyte differentiation,5/81,41/13083,0.12195121951219512,19.697380307136406,9.46400787815456,5.052398753372062e-6,1.2355866258246528e-4,8.072253558019147e-5,CCN2/SMAD7/SMAD3/RUNX2/CTNNB1,5
GO:0060537,muscle tissue development,11/81,328/13083,0.03353658536585366,5.416779584462512,6.3940631040514235,5.268598117605322e-6,1.2758271912240336e-4,8.335150582341546e-5,RUNX1/CDK1/CENPF/TGFB2/FGF2/SMAD7/SMAD3/CTNNB1/CREB1/YAP1/SMAD1,11
GO:0019827,stem cell population maintenance,8/81,159/13083,0.050314465408805034,8.126717912881436,7.1361530777396185,6.050185559350844e-6,1.4508697409317073e-4,9.478727095027946e-5,TET1/MYC/JAG1/SMC3/TP63/CTNNB1/SMARCA2/YAP1,8
GO:0048762,mesenchymal cell differentiation,9/81,214/13083,0.04205607476635514,6.792834890965732,6.743729432871708,6.6662096699179085e-6,1.5832247966055034e-4,1.034342046961959e-4,DAB2/JAG1/TGFB2/SMAD7/SMAD2/SMAD3/GSK3B/CTNNB1/WWTR1,9
GO:0098727,maintenance of cell number,8/81,162/13083,0.04938271604938271,7.976223136716963,7.051870172961722,6.945290805731692e-6,1.6337969800149792e-4,1.067381534354555e-4,TET1/MYC/JAG1/SMC3/TP63/CTNNB1/SMARCA2/YAP1,8
GO:0090090,negative regulation of canonical Wnt signaling pathway,7/81,116/13083,0.0603448275862069,9.746807151979567,7.468498387453515,7.265071425281944e-6,1.692898718910038e-4,1.1059934950305084e-4,LATS2/DAB2/BICC1/GSK3B/CTNNB1/WWTR1/STK3,7
GO:0043010,camera-type eye development,10/81,277/13083,0.036101083032490974,5.830993448321968,6.414223450943579,7.686992877137468e-6,1.7744740566850043e-4,1.1592877600247652e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0016525,negative regulation of angiogenesis,6/81,78/13083,0.07692307692307693,12.424501424501425,7.987371424243355,8.407258430950187e-6,1.9051310389400883e-4,1.244647723287942e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0072080,nephron tubule development,6/81,78/13083,0.07692307692307693,12.424501424501425,7.987371424243355,8.407258430950187e-6,1.9051310389400883e-4,1.244647723287942e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:2000181,negative regulation of blood vessel morphogenesis,6/81,79/13083,0.0759493670886076,12.267229254571028,7.928055782558723,9.053669936282096e-6,2.0220392712783924e-4,1.3210254433708825e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0030856,regulation of epithelial cell differentiation,7/81,120/13083,0.058333333333333334,9.421913580246914,7.315148454525216,9.086897130036501e-6,2.0220392712783924e-4,1.3210254433708825e-4,JAG1/SERPINE1/FGF2/TP63/CTNNB1/WWTR1/YAP1,7
GO:1901343,negative regulation of vasculature development,6/81,80/13083,0.075,12.113888888888887,7.869801237818624,9.739777842625304e-6,2.1479688635075446e-4,1.403296939167725e-4,GADD45A/SERPINE1/TGFB2/THBS1/AMOT/CTNNB1,6
GO:0042063,gliogenesis,10/81,285/13083,0.03508771929824561,5.667316439246264,6.2877189993834754,9.865698398028679e-6,2.1564845170912245e-4,1.4088603301516504e-4,NF2/CDK1/NDRG1/TGFB2/FGF2/PHGDH/ETV5/HEXB/EGFR/CTNNB1,10
GO:0001701,in utero embryonic development,11/81,351/13083,0.03133903133903134,5.061833913685766,6.088382172143893,1.0015609729262744e-5,2.1700487746735946e-4,1.4177220420092141e-4,TET1/GINS1/LATS2/CCN1/SMAD2/SMAD3/AMOT/EGFR/CTNNB1/YAP1/STK3,11
GO:0009880,embryonic pattern specification,5/81,48/13083,0.10416666666666667,16.824845679012345,8.669201260624341,1.1159695849177837e-5,2.3930103402416335e-4,1.5633858306373e-4,SMAD2/SMAD3/CTNNB1/SMAD6/SMAD1,5
GO:0061326,renal tubule development,6/81,82/13083,0.07317073170731707,11.818428184281842,7.756346720929488,1.1238429128260304e-5,2.3930103402416335e-4,1.5633858306373e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,7/81,125/13083,0.056,9.045037037037037,7.1332684357636476,1.1882555258361253e-5,2.50853944343182e-4,1.638862547104616e-4,TET1/LATS2/THBS1/SMAD7/SMAD2/SMAD3/SMAD6,7
GO:0010812,negative regulation of cell-substrate adhesion,5/81,49/13083,0.10204081632653061,16.48148148148148,8.569316833125642,1.2367858298606874e-5,2.588865254030422e-4,1.6913404791939643e-4,NF2/JAG1/SERPINE1/THBS1/DLC1,5
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,7/81,127/13083,0.05511811023622047,8.902595508894722,7.063348672293978,1.3184162324755177e-5,2.7127400145638737e-4,1.7722695258156484e-4,TET1/LATS2/THBS1/SMAD7/SMAD2/SMAD3/SMAD6,7
GO:0061448,connective tissue development,9/81,233/13083,0.03862660944206009,6.238912732474965,6.3685719822168085,1.3223645866182622e-5,2.7127400145638737e-4,1.7722695258156484e-4,RUNX1/CCN2/CCN1/FGF2/SMAD7/SMAD3/RUNX2/CTNNB1/SMAD1,9
GO:0048738,cardiac muscle tissue development,8/81,177/13083,0.04519774011299435,7.300272023435865,6.660772568108016,1.328913124543436e-5,2.7127400145638737e-4,1.7722695258156484e-4,RUNX1/CDK1/TGFB2/FGF2/SMAD7/CREB1/YAP1/SMAD1,8
GO:0045926,negative regulation of growth,8/81,180/13083,0.044444444444444446,7.178600823045268,6.5880296158720055,1.501709148063631e-5,3.0403455702599744e-4,1.9862986401911534e-4,DAB2/INHBA/TGFB2/SLIT2/SMAD3/WWC2/SMARCA2/STK3,8
GO:1900180,regulation of protein localization to nucleus,7/81,130/13083,0.05384615384615385,8.697150997150997,6.961310425848355,1.5356441260375773e-5,3.083773163668956e-4,2.014670470873433e-4,NF2/CDK1/LATS2/SMAD3/GSK3B/WWTR1/YAP1,7
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,6/81,87/13083,0.06896551724137931,11.139208173690932,7.489163566147937,1.5814128884671847e-5,3.150072447188666e-4,2.0579846842276692e-4,DAB2/CCN1/INHBA/TGFB2/THBS1/SMAD2,6
GO:1901654,response to ketone,8/81,183/13083,0.04371584699453552,7.060918842339607,6.516939052297839,1.6930538277719143e-5,3.345474363677303e-4,2.1856433835573433e-4,INHBA/TGFB2/SLIT2/THBS1/SGK1/EGFR/CREB1/YAP1,8
GO:0003206,cardiac chamber morphogenesis,6/81,89/13083,0.06741573033707865,10.88888888888889,7.388317841694952,1.802021355061159e-5,3.5325339261913196e-4,2.3078519108678003e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0003231,cardiac ventricle development,6/81,90/13083,0.06666666666666667,10.767901234567901,7.339091396889955,1.9212782624031887e-5,3.707466646981153e-4,2.4221378094277043e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0003279,cardiac septum development,6/81,90/13083,0.06666666666666667,10.767901234567901,7.339091396889955,1.9212782624031887e-5,3.707466646981153e-4,2.4221378094277043e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0001707,mesoderm formation,5/81,54/13083,0.09259259259259259,14.955418381344307,8.11070676097221,2.0021582971272798e-5,3.804100764541832e-4,2.485270177729652e-4,NF2/INHBA/SMAD2/SMAD3/SMAD1,5
GO:0042475,odontogenesis of dentin-containing tooth,5/81,54/13083,0.09259259259259259,14.955418381344307,8.11070676097221,2.0021582971272798e-5,3.804100764541832e-4,2.485270177729652e-4,NF2/SERPINE1/TP63/RUNX2/CTNNB1,5
GO:0001654,eye development,10/81,312/13083,0.03205128205128205,5.17687559354226,5.893738812828843,2.162042858548622e-5,4.0765235577214476e-4,2.6632476513901467e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0060390,regulation of SMAD protein signal transduction,5/81,55/13083,0.09090909090909091,14.683501683501685,8.026278420698674,2.1917492735603838e-5,4.1012278073440515e-4,2.679387269830996e-4,DAB2/INHBA/TGFB2/SMAD7/SMAD6,5
GO:0150063,visual system development,10/81,315/13083,0.031746031746031744,5.127572016460905,5.852790788809683,2.3471433631853203e-5,4.358980531629881e-4,2.847780590235929e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0048332,mesoderm morphogenesis,5/81,56/13083,0.08928571428571429,14.421296296296296,7.944028107732982,2.395017389852713e-5,4.4146962335344785e-4,2.884180407418861e-4,NF2/INHBA/SMAD2/SMAD3/SMAD1,5
GO:0072009,nephron epithelium development,6/81,94/13083,0.06382978723404255,10.309692671394798,7.149668630867664,2.463658136697885e-5,4.41704600420467e-4,2.8857155441916726e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0048880,sensory system development,10/81,317/13083,0.031545741324921134,5.09522140436967,5.825780244818064,2.4779766553091176e-5,4.41704600420467e-4,2.8857155441916726e-4,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0030178,negative regulation of Wnt signaling pathway,7/81,140/13083,0.05,8.075925925925928,6.643612921441843,2.4845581109055478e-5,4.41704600420467e-4,2.8857155441916726e-4,LATS2/DAB2/BICC1/GSK3B/CTNNB1/WWTR1/STK3,7
GO:0051017,actin filament bundle assembly,7/81,140/13083,0.05,8.075925925925928,6.643612921441843,2.4845581109055478e-5,4.41704600420467e-4,2.8857155441916726e-4,NF2/CCN2/MARCKS/DLC1/ITGB5/SMAD3/AMOT,7
GO:0097191,extrinsic apoptotic signaling pathway,8/81,193/13083,0.04145077720207254,6.695068125119938,6.2910859747068395,2.4857060509491866e-5,4.41704600420467e-4,2.8857155441916726e-4,INHBA/SERPINE1/TGFB2/THBS1/SMAD3/GSK3B/YAP1/STK3,8
GO:0045165,cell fate commitment,8/81,194/13083,0.041237113402061855,6.660557464681175,6.26938524884701,2.5797511483098192e-5,4.551418097375181e-4,2.973502639367634e-4,LATS2/JAG1/ETS2/FGF2/SMAD2/RUNX2/CTNNB1/SMAD1,8
GO:0002067,glandular epithelial cell differentiation,5/81,57/13083,0.08771929824561403,14.168291098115658,7.863860673985083,2.6126444203245127e-5,4.576760083830884e-4,2.990058899856274e-4,FGF2/TP63/GSK3B/CTNNB1/YAP1,5
GO:0072182,regulation of nephron tubule epithelial cell differentiation,3/81,10/13083,0.3,48.45555555555555,11.848788089725641,2.6591547116996585e-5,4.625431083026871e-4,3.021856318039716e-4,CTNNB1/WWTR1/YAP1,3
GO:0061572,actin filament bundle organization,7/81,142/13083,0.04929577464788732,7.962180490349503,6.5838515874791845,2.7228027155347562e-5,4.703022872287306e-4,3.0725480772284e-4,NF2/CCN2/MARCKS/DLC1/ITGB5/SMAD3/AMOT,7
GO:0002062,chondrocyte differentiation,6/81,96/13083,0.0625,10.094907407407407,7.059175501588857,2.7776537053971644e-5,4.7644476752298584e-4,3.112677726881472e-4,RUNX1/CCN2/SMAD7/SMAD3/RUNX2/CTNNB1,6
GO:2001233,regulation of apoptotic signaling pathway,10/81,322/13083,0.031055900621118012,5.0161030595813205,5.75923674527234,2.8328074983803896e-5,4.819550571420279e-4,3.148677189851817e-4,MYC/INHBA/SERPINE1/FGF2/THBS1/TP63/GSK3B/CTNNB1/YAP1/STK3,10
GO:0061138,morphogenesis of a branching epithelium,7/81,143/13083,0.04895104895104895,7.906500906500907,6.5544077399827865,2.8488031717706914e-5,4.819550571420279e-4,3.148677189851817e-4,MYC/FGF2/SLIT2/TGM2/TP63/CTNNB1/YAP1,7
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,4/81,29/13083,0.13793103448275862,22.278416347381864,9.05401058897378,2.8785562671770125e-5,4.8367578094742997e-4,3.1599189098334126e-4,FGF2/THBS1/RUNX2/CTNNB1,4
GO:0060562,epithelial tube morphogenesis,9/81,259/13083,0.03474903474903475,5.612612612612613,5.917790830026699,3.058177882736787e-5,5.103850925918828e-4,3.3344144340224e-4,MYC/TGFB2/FGF2/SLIT2/DLC1/SMAD3/CTNNB1/YAP1/STK3,9
GO:0030038,contractile actin filament bundle assembly,6/81,98/13083,0.061224489795918366,9.88888888888889,6.971304286154159,3.1230751387610176e-5,5.142663728493142e-4,3.3597713598039583e-4,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0043149,stress fiber assembly,6/81,98/13083,0.061224489795918366,9.88888888888889,6.971304286154159,3.1230751387610176e-5,5.142663728493142e-4,3.3597713598039583e-4,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0040017,positive regulation of locomotion,12/81,473/13083,0.02536997885835095,4.097721400046981,5.416140028973281,3.176012025440035e-5,5.195198478699925e-4,3.3940930184730387e-4,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT/FAT1/EGFR,12
GO:0048863,stem cell differentiation,8/81,200/13083,0.04,6.460740740740741,6.142321627687772,3.2089976579098036e-5,5.21462119410343e-4,3.4067821395953804e-4,JAG1/TGFB2/FGF2/TP63/RUNX2/GSK3B/CTNNB1/YAP1,8
GO:0060043,regulation of cardiac muscle cell proliferation,4/81,30/13083,0.13333333333333333,21.535802469135803,8.887746062589589,3.3058211929170327e-5,5.336848592486975e-4,3.486634942374827e-4,RUNX1/CDK1/FGF2/YAP1,4
GO:0003281,ventricular septum development,5/81,60/13083,0.08333333333333333,13.459876543209877,7.63498775905715,3.358773078363507e-5,5.387123054258352e-4,3.5194799242182205e-4,CCN1/TGFB2/SLIT2/SMAD7/SMAD6,5
GO:0045927,positive regulation of growth,8/81,202/13083,0.039603960396039604,6.396773010634397,6.101119726380958,3.445375304301219e-5,5.490372259112265e-4,3.586934017992372e-4,CDK1/TGFB2/FGF2/SMAD7/TEAD1/EGFR/CREB1/YAP1,8
GO:0009950,dorsal/ventral axis specification,3/81,11/13083,0.2727272727272727,44.05050505050505,11.274001149141675,3.6400122664113056e-5,5.72664350193371e-4,3.741293197726136e-4,SMAD2/CTNNB1/SMAD6,3
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,3/81,11/13083,0.2727272727272727,44.05050505050505,11.274001149141675,3.6400122664113056e-5,5.72664350193371e-4,3.741293197726136e-4,CTNNB1/WWTR1/YAP1,3
GO:0048545,response to steroid hormone,9/81,268/13083,0.033582089552238806,5.42412935323383,5.775776896200324,3.995460015895256e-5,6.246067240038786e-4,4.080639709771771e-4,DAB2/INHBA/TGFB2/SLIT2/THBS1/SGK1/TP63/EGFR/YAP1,9
GO:0043588,skin development,8/81,208/13083,0.038461538461538464,6.212250712250713,5.980780269454511,4.243741984028456e-5,6.551276687843929e-4,4.280037145733963e-4,LATS2/INHBA/JAG1/TGFB2/TP63/EGFR/CTNNB1/YAP1,8
GO:0097305,response to alcohol,8/81,208/13083,0.038461538461538464,6.212250712250713,5.980780269454511,4.243741984028456e-5,6.551276687843929e-4,4.280037145733963e-4,CDK1/INHBA/FGF2/SLIT2/SGK1/SMAD2/CTNNB1/CREB1,8
GO:0003180,aortic valve morphogenesis,4/81,32/13083,0.125,20.189814814814813,8.578243681462684,4.297180134177675e-5,6.592568280384383e-4,4.307013498329112e-4,JAG1/SLIT2/SMAD2/SMAD6,4
GO:0008543,fibroblast growth factor receptor signaling pathway,5/81,64/13083,0.078125,12.61863425925926,7.354120731287103,4.599219986612788e-5,7.012390967242954e-4,4.581289304403772e-4,CCN2/FGF2/THBS1/RUNX2/CTNNB1,5
GO:0072160,nephron tubule epithelial cell differentiation,3/81,12/13083,0.25,40.379629629629626,10.771652736739972,4.83168482969461e-5,7.321632840089379e-4,4.783321177863634e-4,CTNNB1/WWTR1/YAP1,3
GO:0002088,lens development in camera-type eye,5/81,65/13083,0.07692307692307693,12.424501424501425,7.287797585704611,4.958471506358946e-5,7.467941841894266e-4,4.8789068159488225e-4,NF2/FGF2/SMAD3/FAT1/CTNNB1,5
GO:2000036,regulation of stem cell population maintenance,5/81,66/13083,0.07575757575757576,12.23625140291807,7.222914333472701,5.3390456369524747e-5,7.853896739627293e-4,5.131056340016468e-4,TET1/MYC/TP63/SMARCA2/YAP1,5
GO:0003013,circulatory system process,11/81,421/13083,0.026128266033254157,4.22019882114894,5.300869113811886,5.3657530620678274e-5,7.853896739627293e-4,5.131056340016468e-4,MYOF/TGFB2/DDAH1/SLIT2/SGK1/SMAD7/SMAD3/AMOT/EGFR/WWTR1/YAP1,11
GO:0001763,morphogenesis of a branching structure,7/81,158/13083,0.04430379746835443,7.155883731833099,6.1443815605511345,5.393723242045691e-5,7.853896739627293e-4,5.131056340016468e-4,MYC/FGF2/SLIT2/TGM2/TP63/CTNNB1/YAP1,7
GO:0050679,positive regulation of epithelial cell proliferation,7/81,158/13083,0.04430379746835443,7.155883731833099,6.1443815605511345,5.393723242045691e-5,7.853896739627293e-4,5.131056340016468e-4,MYC/FGF2/TP63/RUNX2/EGFR/CTNNB1/YAP1,7
GO:0043534,blood vessel endothelial cell migration,6/81,108/13083,0.05555555555555555,8.973251028806583,6.567016886653578,5.4055159746422663e-5,7.853896739627293e-4,5.131056340016468e-4,ETS1/GADD45A/FGF2/SLIT2/THBS1/AMOT,6
GO:0045598,regulation of fat cell differentiation,6/81,108/13083,0.05555555555555555,8.973251028806583,6.567016886653578,5.4055159746422663e-5,7.853896739627293e-4,5.131056340016468e-4,JAG1/SMAD3/CREB1/WWTR1/YAP1/STK3,6
GO:0016202,regulation of striated muscle tissue development,4/81,34/13083,0.11764705882352941,19.002178649237475,8.295649820828006,5.4900037612627585e-5,7.930005432935095e-4,5.180779172678246e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:0030324,lung development,7/81,159/13083,0.0440251572327044,7.110878173771256,6.11896845371535,5.614255694695531e-5,8.062332305754629e-4,5.267230097899786e-4,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0010720,positive regulation of cell development,10/81,350/13083,0.02857142857142857,4.614814814814815,5.410397915945312,5.736730853464171e-5,8.190592605813008e-4,5.351024276459127e-4,RUNX1/FGF2/SLIT2/ETV5/TGM2/SMAD7/EGFR/CTNNB1/CREB1/SMARCA2,10
GO:0034504,protein localization to nucleus,9/81,283/13083,0.03180212014134275,5.13663133097762,5.552768285177745,6.096985713953245e-5,8.560795390160043e-4,5.592882733055762e-4,NF2/NUAK2/CDK1/LATS2/SMAD3/GSK3B/WWTR1/YAP1/STK3,9
GO:0048568,embryonic organ development,10/81,353/13083,0.028328611898016998,4.575595425453782,5.37521728739034,6.161941241711688e-5,8.560795390160043e-4,5.592882733055762e-4,CCN1/TGFB2/TEAD1/SMAD2/SMAD3/RUNX2/EGFR/CTNNB1/YAP1/STK3,10
GO:0035850,epithelial cell differentiation involved in kidney development,4/81,35/13083,0.11428571428571428,18.45925925925926,8.16323620665774,6.169318135418978e-5,8.560795390160043e-4,5.592882733055762e-4,JAG1/CTNNB1/WWTR1/YAP1,4
GO:0048634,regulation of muscle organ development,4/81,35/13083,0.11428571428571428,18.45925925925926,8.16323620665774,6.169318135418978e-5,8.560795390160043e-4,5.592882733055762e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:1901861,regulation of muscle tissue development,4/81,35/13083,0.11428571428571428,18.45925925925926,8.16323620665774,6.169318135418978e-5,8.560795390160043e-4,5.592882733055762e-4,CENPF/SMAD3/CTNNB1/CREB1,4
GO:0030214,hyaluronan catabolic process,3/81,13/13083,0.23076923076923078,37.27350427350427,10.327564043954553,6.253158468872032e-5,8.580723010063288e-4,5.605901715076507e-4,FGF2/HMMR/HEXB,3
GO:0035332,positive regulation of hippo signaling,3/81,13/13083,0.23076923076923078,37.27350427350427,10.327564043954553,6.253158468872032e-5,8.580723010063288e-4,5.605901715076507e-4,SCHIP1/FRMD6/STK3,3
GO:0030323,respiratory tube development,7/81,163/13083,0.04294478527607362,6.9363780958872985,6.019474795155112,6.571624581714899e-5,8.96790757836232e-4,5.85885459945853e-4,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0030857,negative regulation of epithelial cell differentiation,4/81,36/13083,0.1111111111111111,17.946502057613166,8.036195414625867,6.907933574929116e-5,9.375052708832371e-4,6.124847987487758e-4,JAG1/TP63/CTNNB1/YAP1,4
GO:0045637,regulation of myeloid cell differentiation,7/81,165/13083,0.04242424242424243,6.85230078563412,5.970978014318734,7.098137343544629e-5,9.580546031997396e-4,6.259099538483704e-4,RUNX1/ETS1/MYC/INHBA/JAG1/CTNNB1/CREB1,7
GO:0071407,cellular response to organic cyclic compound,11/81,435/13083,0.02528735632183908,4.084376330353342,5.163873118410967,7.202407101420289e-5,9.668448663319627e-4,6.316527509426374e-4,CDK1/DAB2/INHBA/TGM2/SGK1/TP63/GSK3B/EGFR/CTNNB1/CREB1/SMAD1,11
GO:0009611,response to wounding,11/81,436/13083,0.02522935779816514,4.075008494733265,5.154307282849484,7.352100478005187e-5,9.816047665228546e-4,6.412955921924297e-4,CDK1/CCN2/CCN1/MYOF/SERPINE1/TGFB2/FGF2/THBS1/ITGB5/SMAD3/YAP1,11
GO:0007492,endoderm development,5/81,71/13083,0.07042253521126761,11.37454355764215,6.918320007298047,7.592670605776701e-5,0.0010082739997993792,6.58718960874685e-4,INHBA/ITGB5/SMAD2/SMAD3/CTNNB1,5
GO:0003176,aortic valve development,4/81,37/13083,0.10810810810810811,17.461461461461464,7.914164362587376,7.708940473103945e-5,0.0010128235621578055,6.616912511348459e-4,JAG1/SLIT2/SMAD2/SMAD6,4
GO:2000648,positive regulation of stem cell proliferation,4/81,37/13083,0.10810810810810811,17.461461461461464,7.914164362587376,7.708940473103945e-5,0.0010128235621578055,6.616912511348459e-4,FGF2/TP63/RUNX2/CTNNB1,4
GO:0043116,negative regulation of vascular permeability,3/81,14/13083,0.21428571428571427,34.611111111111114,9.931165272453141,7.92305630404288e-5,0.0010283718204758083,6.718491373489939e-4,DDAH1/SLIT2/AMOT,3
GO:0072202,cell differentiation involved in metanephros development,3/81,14/13083,0.21428571428571427,34.611111111111114,9.931165272453141,7.92305630404288e-5,0.0010283718204758083,6.718491373489939e-4,CTNNB1/WWTR1/YAP1,3
GO:0045216,cell-cell junction organization,7/81,168/13083,0.041666666666666664,6.729938271604938,5.899726512218657,7.952186951857465e-5,0.0010283718204758083,6.718491373489939e-4,NF2/TGFB2/SMAD7/SMAD3/MPDZ/AMOT/CTNNB1,7
GO:0035148,tube formation,6/81,116/13083,0.05172413793103448,8.3544061302682,6.2795908690127495,8.059340954064355e-5,0.0010338326956439072,6.754168005208225e-4,TGFB2/FGF2/DLC1/TGM2/CTNNB1/STK3,6
GO:0070371,ERK1 and ERK2 cascade,8/81,228/13083,0.03508771929824561,5.667316439246264,5.611424585333675,8.105202341668413e-5,0.0010338326956439072,6.754168005208225e-4,CDK1/CCN2/DAB2/CCN1/MYC/INHBA/FGF2/EGFR,8
GO:2000736,regulation of stem cell differentiation,5/81,72/13083,0.06944444444444445,11.216563786008232,6.86104490223954,8.119981496150527e-5,0.0010338326956439072,6.754168005208225e-4,JAG1/TGFB2/FGF2/GSK3B/YAP1,5
GO:1903670,regulation of sprouting angiogenesis,4/81,38/13083,0.10526315789473684,17.00194931773879,7.796813538084934,8.57547960411976e-5,0.0010862274165218363,7.096469761465908e-4,FGF2/THBS1/TGM2/SMAD1,4
GO:0001942,hair follicle development,5/81,73/13083,0.0684931506849315,11.062912227295788,6.804887776440935,8.675049355499106e-5,0.001093233260616469,7.142239882910919e-4,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0045785,positive regulation of cell adhesion,10/81,369/13083,0.02710027100271003,4.37719562380809,5.194010202343777,8.912995873026168e-5,0.0011175177566687632,7.300893760806367e-4,RUNX1/DAB2/CCN1/ETS1/TGFB2/TGM2/SMAD7/SMAD3/GSK3B/SMARCA2,10
GO:0030335,positive regulation of cell migration,11/81,446/13083,0.02466367713004484,3.9836405912639092,5.060185578125857,9.002255082239716e-5,0.0011230085885420252,7.33676610370733e-4,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/THBS1/SMAD3/AMOT/FAT1/EGFR,11
GO:0045747,positive regulation of Notch signaling pathway,4/81,39/13083,0.10256410256410256,16.566001899335234,7.683843105647107,9.510740227540846e-5,0.001180478812162105,7.712226801809107e-4,JAG1/TGFB2/TP63/YAP1,4
GO:0022404,molting cycle process,5/81,76/13083,0.06578947368421052,10.626218323586743,6.642758048942428,1.0516786090908434e-4,0.0012734978830046626,8.319932898555926e-4,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0022405,hair cycle process,5/81,76/13083,0.06578947368421052,10.626218323586743,6.642758048942428,1.0516786090908434e-4,0.0012734978830046626,8.319932898555926e-4,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:1902106,negative regulation of leukocyte differentiation,5/81,76/13083,0.06578947368421052,10.626218323586743,6.642758048942428,1.0516786090908434e-4,0.0012734978830046626,8.319932898555926e-4,RUNX1/MYC/INHBA/SMAD7/CTNNB1,5
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/81,40/13083,0.1,16.151851851851855,7.574979552239316,1.0517958224006121e-4,0.0012734978830046626,8.319932898555926e-4,RUNX1/MYC/INHBA/CTNNB1,4
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,4/81,40/13083,0.1,16.151851851851855,7.574979552239316,1.0517958224006121e-4,0.0012734978830046626,8.319932898555926e-4,SERPINE1/THBS1/GSK3B/STK3,4
GO:0046330,positive regulation of JNK cascade,5/81,77/13083,0.06493506493506493,10.488215488215488,6.5907149421995825,1.1192960302599285e-4,0.0013486152169473284,8.810684541147475e-4,CCN2/GADD45B/GADD45A/TAOK1/STK3,5
GO:0072006,nephron development,6/81,124/13083,0.04838709677419355,7.815412186379928,6.018547952642135,1.1662241261811262e-4,0.001398336694984166,9.13552164249191e-4,MYC/JAG1/FGF2/CTNNB1/WWTR1/YAP1,6
GO:0048511,rhythmic process,8/81,241/13083,0.03319502074688797,5.36161057322883,5.394032718729946,1.1920142029315007e-4,0.001414201247448363,9.239166896817986e-4,CDK1/INHBA/TGFB2/SLIT2/USP9X/GSK3B/EGFR/CREB1,8
GO:2000147,positive regulation of cell motility,11/81,461/13083,0.02386117136659436,3.8540210492488147,4.924000037895269,1.2069217890049731e-4,0.001414201247448363,9.239166896817986e-4,DAB2/CCN1/ETS1/SERPINE1/TGFB2/FGF2/THBS1/SMAD3/AMOT/FAT1/EGFR,11
GO:0032332,positive regulation of chondrocyte differentiation,3/81,16/13083,0.1875,30.28472222222222,9.2509781604619,1.2080828470105448e-4,0.001414201247448363,9.239166896817986e-4,SMAD7/SMAD3/RUNX2,3
GO:0048339,paraxial mesoderm development,3/81,16/13083,0.1875,30.28472222222222,9.2509781604619,1.2080828470105448e-4,0.001414201247448363,9.239166896817986e-4,SMAD2/SMAD3/YAP1,3
GO:0071895,odontoblast differentiation,3/81,16/13083,0.1875,30.28472222222222,9.2509781604619,1.2080828470105448e-4,0.001414201247448363,9.239166896817986e-4,SERPINE1/SMAD2/CTNNB1,3
GO:0002064,epithelial cell development,7/81,180/13083,0.03888888888888889,6.28127572016461,5.631242711821859,1.2250438131830804e-4,0.0014272916125293437,9.324688011964561e-4,AMOTL2/JAG1/TP63/GSK3B/FAT1/FRMD6/YAP1,7
GO:0045639,positive regulation of myeloid cell differentiation,5/81,79/13083,0.06329113924050633,10.222691045475855,6.489440076332343,1.2645034380584998e-4,0.0014635763727829096,9.561741229389306e-4,RUNX1/ETS1/INHBA/JAG1/CREB1,5
GO:0060541,respiratory system development,7/81,181/13083,0.03867403314917127,6.246572539390218,5.6099753302545965,1.26803782905078e-4,0.0014635763727829096,9.561741229389306e-4,CCN2/FGF2/SMAD2/EGFR/CTNNB1/CREB1/YAP1,7
GO:0045668,negative regulation of osteoblast differentiation,4/81,42/13083,0.09523809523809523,15.382716049382717,7.368593611374477,1.276143199323296e-4,0.001466080791780717,9.578102935435071e-4,CRIM1/SMAD3/GSK3B/SMAD6,4
GO:1903706,regulation of hemopoiesis,9/81,313/13083,0.02875399361022364,4.644302449414271,5.150692631651362,1.3163827344391815e-4,0.001505308034289249,9.834379785064646e-4,RUNX1/ETS1/MYC/INHBA/JAG1/SMAD7/CTNNB1/CREB1/SMARCA2,9
GO:0003205,cardiac chamber development,6/81,127/13083,0.047244094488188976,7.630796150481189,5.926612988484323,1.3303485453252948e-4,0.0015142676990569023,9.892914479668578e-4,CCN1/JAG1/TGFB2/SLIT2/SMAD7/SMAD6,6
GO:0061005,cell differentiation involved in kidney development,4/81,43/13083,0.09302325581395349,15.024978466838931,7.270631542100308,1.4004376282558895e-4,0.001586734376968829,0.0010366349030015833,JAG1/CTNNB1/WWTR1/YAP1,4
GO:2001236,regulation of extrinsic apoptotic signaling pathway,6/81,129/13083,0.046511627906976744,7.5124892334194655,5.866977573087167,1.449581183801941e-4,0.0016322311448085927,0.001066358553160696,INHBA/SERPINE1/THBS1/GSK3B/YAP1/STK3,6
GO:0010755,regulation of plasminogen activation,3/81,17/13083,0.17647058823529413,28.50326797385621,8.955955666395749,1.4604173400918987e-4,0.0016322311448085927,0.001066358553160696,RUNX1/SERPINE1/THBS1,3
GO:0060571,morphogenesis of an epithelial fold,3/81,17/13083,0.17647058823529413,28.50326797385621,8.955955666395749,1.4604173400918987e-4,0.0016322311448085927,0.001066358553160696,TP63/EGFR/CTNNB1,3
GO:0051492,regulation of stress fiber assembly,5/81,82/13083,0.06097560975609756,9.848690153568203,6.344129450974015,1.508886505517225e-4,0.001678806157039435,0.0010967866348780967,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:0072132,mesenchyme morphogenesis,4/81,44/13083,0.09090909090909091,14.683501683501685,7.175892871451774,1.5332651461563682e-4,0.0016982802291507755,0.0011095093080281864,MYC/TGFB2/SMAD2/SMAD3,4
GO:1903707,negative regulation of hemopoiesis,5/81,83/13083,0.060240963855421686,9.730031236055332,6.297347637009318,1.5978825744536514e-4,0.0017619508745091602,0.0011511061967281239,RUNX1/MYC/INHBA/SMAD7/CTNNB1,5
GO:0010596,negative regulation of endothelial cell migration,4/81,45/13083,0.08888888888888889,14.357201646090536,7.084198992200079,1.6749699615958708e-4,0.00183060876333708,0.0011959613186429763,GADD45A/FGF2/SLIT2/THBS1,4
GO:0055021,regulation of cardiac muscle tissue growth,4/81,45/13083,0.08888888888888889,14.357201646090536,7.084198992200079,1.6749699615958708e-4,0.00183060876333708,0.0011959613186429763,RUNX1/CDK1/FGF2/YAP1,4
GO:0043535,regulation of blood vessel endothelial cell migration,5/81,84/13083,0.05952380952380952,9.614197530864198,6.251352642774791,1.6908381452224454e-4,0.0018398106690305904,0.001201973047357296,ETS1/GADD45A/FGF2/THBS1/AMOT,5
GO:0007398,ectoderm development,3/81,18/13083,0.16666666666666666,26.919753086419753,8.685341648078797,1.744689225057399e-4,0.0018818263693850547,0.0012294224693233707,NF2/ETS2/CTNNB1,3
GO:0031053,primary miRNA processing,3/81,18/13083,0.16666666666666666,26.919753086419753,8.685341648078797,1.744689225057399e-4,0.0018818263693850547,0.0012294224693233707,SMAD2/SMAD3/SMAD1,3
GO:0007015,actin filament organization,10/81,401/13083,0.02493765586034913,4.027893229888242,4.860639029189432,1.7626759307971113e-4,0.0018929606735082023,0.001236696659913946,NF2/CCN2/MARCKS/SLIT2/DLC1/ITGB5/SMAD3/AMOT/FAT1/ENAH,10
GO:0051496,positive regulation of stress fiber assembly,4/81,46/13083,0.08695652173913043,14.045088566827697,6.995384913314094,1.825899890012098e-4,0.0019391822046222528,0.0012668938076649961,NF2/CCN2/SMAD3/AMOT,4
GO:1902459,positive regulation of stem cell population maintenance,4/81,46/13083,0.08695652173913043,14.045088566827697,6.995384913314094,1.825899890012098e-4,0.0019391822046222528,0.0012668938076649961,TET1/TP63/SMARCA2/YAP1,4
GO:0042060,wound healing,9/81,327/13083,0.027522935779816515,4.445463812436289,4.980108617341945,1.8292690432266594e-4,0.0019391822046222528,0.0012668938076649961,CCN1/MYOF/SERPINE1/TGFB2/FGF2/THBS1/ITGB5/SMAD3/YAP1,9
GO:0043542,endothelial cell migration,7/81,193/13083,0.03626943005181347,5.858184609479945,5.366618342004864,1.886734530741554e-4,0.0019830784216730377,0.001295571796473372,ETS1/GADD45A/FSTL1/FGF2/SLIT2/THBS1/AMOT,7
GO:0045444,fat cell differentiation,7/81,193/13083,0.03626943005181347,5.858184609479945,5.366618342004864,1.886734530741554e-4,0.0019830784216730377,0.001295571796473372,JAG1/SMAD3/CREB1/WWTR1/YAP1/SMAD6/STK3,7
GO:0030514,negative regulation of BMP signaling pathway,4/81,47/13083,0.0851063829787234,13.746256895193065,6.909297951791334,1.9864061880522322e-4,0.0020789929171563617,0.001358234025996464,CRIM1/SMAD7/UBE2D1/SMAD6,4
GO:0030900,forebrain development,9/81,331/13083,0.027190332326283987,4.391742195367573,4.933125681879473,2.0032118717708383e-4,0.0020877355794404937,0.0013639457248166536,NF2/INHBA/FGF2/SLIT2/DLC1/GSK3B/EGFR/CTNNB1/CREB1,9
GO:0014912,negative regulation of smooth muscle cell migration,3/81,19/13083,0.15789473684210525,25.502923976608184,8.435894274549337,2.062585806863974e-4,0.002122744559564173,0.0013868175622466985,IGFBP3/SERPINE1/SLIT2,3
GO:0031639,plasminogen activation,3/81,19/13083,0.15789473684210525,25.502923976608184,8.435894274549337,2.062585806863974e-4,0.002122744559564173,0.0013868175622466985,RUNX1/SERPINE1/THBS1,3
GO:1903672,positive regulation of sprouting angiogenesis,3/81,19/13083,0.15789473684210525,25.502923976608184,8.435894274549337,2.062585806863974e-4,0.002122744559564173,0.0013868175622466985,FGF2/TGM2/SMAD1,3
GO:0030308,negative regulation of cell growth,6/81,138/13083,0.043478260869565216,7.022544283413849,5.613620103569961,2.0951343855269601e-4,0.0021392761677114904,0.0013976178841260236,DAB2/INHBA/TGFB2/SLIT2/SMAD3/SMARCA2,6
GO:0042303,molting cycle,5/81,88/13083,0.056818181818181816,9.177188552188552,6.074796123079057,2.1046320192465268e-4,0.0021392761677114904,0.0013976178841260236,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0042633,hair cycle,5/81,88/13083,0.056818181818181816,9.177188552188552,6.074796123079057,2.1046320192465268e-4,0.0021392761677114904,0.0013976178841260236,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0002761,regulation of myeloid leukocyte differentiation,5/81,89/13083,0.056179775280898875,9.074074074074074,6.032409323930709,2.219181417088215e-4,0.0022464664345114307,0.0014676467266592898,RUNX1/MYC/INHBA/CTNNB1/CREB1,5
GO:0045599,negative regulation of fat cell differentiation,4/81,49/13083,0.08163265306122448,13.185185185185185,6.744749373440995,2.3375691514287457e-4,0.0023470714650524398,0.001533373345802425,JAG1/SMAD3/WWTR1/YAP1,4
GO:0060420,regulation of heart growth,4/81,49/13083,0.08163265306122448,13.185185185185185,6.744749373440995,2.3375691514287457e-4,0.0023470714650524398,0.001533373345802425,RUNX1/CDK1/FGF2/YAP1,4
GO:0060045,positive regulation of cardiac muscle cell proliferation,3/81,20/13083,0.15,24.227777777777774,8.204945446552587,2.4157606529405932e-4,0.0024157606529405934,0.0015782489158141615,CDK1/FGF2/YAP1,3
GO:0032231,regulation of actin filament bundle assembly,5/81,91/13083,0.054945054945054944,8.874643874643874,5.949604725691979,2.46247438244032e-4,0.0024329246898510365,0.001589462411907794,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:0044344,cellular response to fibroblast growth factor stimulus,5/81,91/13083,0.054945054945054944,8.874643874643874,5.949604725691979,2.46247438244032e-4,0.0024329246898510365,0.001589462411907794,CCN2/FGF2/THBS1/RUNX2/CTNNB1,5
GO:0110020,regulation of actomyosin structure organization,5/81,91/13083,0.054945054945054944,8.874643874643874,5.949604725691979,2.46247438244032e-4,0.0024329246898510365,0.001589462411907794,NF2/CCN2/DLC1/SMAD3/AMOT,5
GO:0001706,endoderm formation,4/81,50/13083,0.08,12.921481481481482,6.666034147014823,2.5289440845155354e-4,0.00247876662252118,0.001619411562891527,INHBA/ITGB5/SMAD2/CTNNB1,4
GO:0061045,negative regulation of wound healing,4/81,50/13083,0.08,12.921481481481482,6.666034147014823,2.5289440845155354e-4,0.00247876662252118,0.001619411562891527,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0010721,negative regulation of cell development,7/81,204/13083,0.03431372549019608,5.542302106027597,5.160889121605471,2.6497333228240385e-4,0.002586893797381571,0.001690052500057937,RUNX1/NF2/MYC/INHBA/SMAD7/GSK3B/CTNNB1,7
GO:0007389,pattern specification process,9/81,345/13083,0.02608695652173913,4.213526570048309,4.774361741600672,2.7244786968948757e-4,0.0026456427760154907,0.0017284339977122302,ETS2/BICC1/FGF2/SMAD2/TP63/SMAD3/CTNNB1/SMAD6/SMAD1,9
GO:0043536,positive regulation of blood vessel endothelial cell migration,4/81,51/13083,0.0784313725490196,12.668119099491648,6.589537090084907,2.731331610866195e-4,0.0026456427760154907,0.0017284339977122302,ETS1/FGF2/THBS1/AMOT,4
GO:0031069,hair follicle morphogenesis,3/81,21/13083,0.14285714285714285,23.074074074074073,7.990276427843073,2.80583400484247e-4,0.002707191403109727,0.0017686445433484814,TGFB2/TP63/CTNNB1,3
GO:0009913,epidermal cell differentiation,6/81,146/13083,0.0410958904109589,6.6377473363774735,5.406793067209393,2.842445555254103e-4,0.002731844560886239,0.0017847507827993203,LATS2/JAG1/FGF2/TP63/CTNNB1/YAP1,6
GO:0071774,response to fibroblast growth factor,5/81,96/13083,0.052083333333333336,8.412422839506172,5.753284928821019,3.1595383573879913e-4,0.002992116542711026,0.001954789968027276,CCN2/FGF2/THBS1/RUNX2/CTNNB1,5
GO:0007254,JNK cascade,6/81,149/13083,0.040268456375838924,6.504101416853094,5.333197100943983,3.17127733857089e-4,0.002992116542711026,0.001954789968027276,CCN2/GADD45B/GADD45A/TAOK1/SMAD3/STK3,6
GO:0010594,regulation of endothelial cell migration,6/81,149/13083,0.040268456375838924,6.504101416853094,5.333197100943983,3.17127733857089e-4,0.002992116542711026,0.001954789968027276,ETS1/GADD45A/FGF2/SLIT2/THBS1/AMOT,6
GO:0003171,atrioventricular valve development,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,CCN1/TGFB2/SMAD6,3
GO:0003181,atrioventricular valve morphogenesis,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,CCN1/TGFB2/SMAD6,3
GO:0006027,glycosaminoglycan catabolic process,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,FGF2/HMMR/HEXB,3
GO:0030859,polarized epithelial cell differentiation,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,TP63/FAT1/YAP1,3
GO:0033688,regulation of osteoblast proliferation,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,NF2/CCN1/SMAD3,3
GO:0060795,cell fate commitment involved in formation of primary germ layer,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,ETS2/CTNNB1/SMAD1,3
GO:0120255,olefinic compound biosynthetic process,3/81,22/13083,0.13636363636363635,22.025252525252526,7.790024925880273,3.234393185845522e-4,0.002992116542711026,0.001954789968027276,DAB2/INHBA/CREB1,3
GO:0030278,regulation of ossification,5/81,97/13083,0.05154639175257732,8.32569683085147,5.715728752139246,3.315239924478476e-4,0.003055463661739491,0.001996175492625885,CCN1/SMAD7/SMAD3/RUNX2/SMAD6,5
GO:0032233,positive regulation of actin filament bundle assembly,4/81,54/13083,0.07407407407407407,11.964334705075446,6.372328022848664,3.408242884189212e-4,0.0031295018304637007,0.002044545623737845,NF2/CCN2/SMAD3/AMOT,4
GO:0048732,gland development,9/81,356/13083,0.025280898876404494,4.083333333333333,4.655399503524827,3.432161488687708e-4,0.003139792176688385,0.00205126844528587,TGFB2/FGF2/TGM2/SMAD2/TP63/SMAD3/EGFR/CTNNB1/CREB1,9
GO:0008015,blood circulation,9/81,357/13083,0.025210084033613446,4.071895424836601,4.6448220128345525,3.503414343276865e-4,0.0031931488663814967,0.0020861270880728044,MYOF/TGFB2/DDAH1/SLIT2/SGK1/SMAD7/SMAD3/AMOT/EGFR,9
GO:0051338,regulation of transferase activity,10/81,439/13083,0.022779043280182234,3.679237323884249,4.506876963994433,3.641652527071337e-4,0.0033069418168625744,0.0021604695526317185,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/SMAD7/GSK3B/EGFR/WWTR1,10
GO:0001702,gastrulation with mouth forming second,3/81,23/13083,0.13043478260869565,21.067632850241548,7.602614634136142,3.702993004516286e-4,0.003338099533268331,0.0021808253076924574,ETS2/AMOT/CTNNB1,3
GO:0055023,positive regulation of cardiac muscle tissue growth,3/81,23/13083,0.13043478260869565,21.067632850241548,7.602614634136142,3.702993004516286e-4,0.003338099533268331,0.0021808253076924574,CDK1/FGF2/YAP1,3
GO:0003151,outflow tract morphogenesis,4/81,56/13083,0.07142857142857142,11.537037037037036,6.23684304008288,3.921355409058078e-4,0.0035093289349179173,0.002292691778064849,JAG1/TGFB2/CTNNB1/SMAD6,4
GO:0042698,ovulation cycle,4/81,56/13083,0.07142857142857142,11.537037037037036,6.23684304008288,3.921355409058078e-4,0.0035093289349179173,0.002292691778064849,INHBA/TGFB2/SLIT2/EGFR,4
GO:0042326,negative regulation of phosphorylation,7/81,218/13083,0.03211009174311927,5.186374447842338,4.9196694470947095,3.9615296170063003e-4,0.003532483088088651,0.0023078186976517798,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:0035270,endocrine system development,5/81,102/13083,0.049019607843137254,7.917574437182281,5.535723032111138,4.1827354657055475e-4,0.003716315323846296,0.0024279187689990934,FGF2/SMAD2/SMAD3/GSK3B/CREB1,5
GO:0060479,lung cell differentiation,3/81,24/13083,0.125,20.189814814814813,7.426701087657738,4.21315615429251e-4,0.0037166056075366065,0.0024281084152369993,CTNNB1/CREB1/YAP1,3
GO:0060487,lung epithelial cell differentiation,3/81,24/13083,0.125,20.189814814814813,7.426701087657738,4.21315615429251e-4,0.0037166056075366065,0.0024281084152369993,CTNNB1/CREB1/YAP1,3
GO:0007162,negative regulation of cell adhesion,7/81,221/13083,0.03167420814479638,5.115971174794703,4.870670042527556,4.3008482068124026e-4,0.0037804608792977347,0.0024698259228482537,RUNX1/NF2/JAG1/SERPINE1/THBS1/DLC1/SMAD7,7
GO:0098773,skin epidermis development,5/81,104/13083,0.04807692307692308,7.76531339031339,5.467118328087571,4.5739039146675605e-4,0.00400622080469109,0.0026173179175757264,INHBA/TGFB2/TP63/EGFR/CTNNB1,5
GO:0031400,negative regulation of protein modification process,8/81,295/13083,0.02711864406779661,4.380163214061518,4.634702543540884,4.6939953518246454e-4,0.004056852921168438,0.0026503965600473967,IGFBP3/LATS2/GADD45A/SLIT2/SMAD7/GSK3B/CTNNB1/WWTR1,8
GO:0007423,sensory organ development,10/81,454/13083,0.022026431718061675,3.5576766193506284,4.377877238859293,4.7444506981479293e-4,0.004056852921168438,0.0026503965600473967,NF2/INHBA/JAG1/FJX1/TGFB2/FGF2/SMAD3/FAT1/EGFR/CTNNB1,10
GO:0003382,epithelial cell morphogenesis,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,AMOTL2/FAT1/FRMD6,3
GO:0007435,salivary gland morphogenesis,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,TGFB2/TGM2/EGFR,3
GO:0030212,hyaluronan metabolic process,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,FGF2/HMMR/HEXB,3
GO:0048730,epidermis morphogenesis,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,TGFB2/TP63/CTNNB1,3
GO:0071634,regulation of transforming growth factor beta production,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,TGFB2/THBS1/SMAD3,3
GO:2000737,negative regulation of stem cell differentiation,3/81,25/13083,0.12,19.38222222222222,7.261129547278866,4.7663736091090633e-4,0.004056852921168438,0.0026503965600473967,JAG1/GSK3B/YAP1,3
GO:0072175,epithelial tube formation,5/81,105/13083,0.047619047619047616,7.691358024691358,5.43349827187144,4.779531174332047e-4,0.004056852921168438,0.0026503965600473967,TGFB2/FGF2/DLC1/CTNNB1/STK3,5
GO:0014910,regulation of smooth muscle cell migration,4/81,60/13083,0.06666666666666667,10.767901234567901,5.98543702250782,5.109548711332216e-4,0.004322118259243347,0.0028236979720520144,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:1902105,regulation of leukocyte differentiation,7/81,228/13083,0.03070175438596491,4.95890188434048,4.759711421730718,5.183500310236105e-4,0.004369708452656376,0.0028547892852854146,RUNX1/MYC/INHBA/SMAD7/CTNNB1/CREB1/SMARCA2,7
GO:0050921,positive regulation of chemotaxis,5/81,107/13083,0.04672897196261682,7.547594323295257,5.3675702223597925,5.211609939891018e-4,0.0043784614120853105,0.0028605077113687542,SERPINE1/FGF2/SLIT2/THBS1/SMAD3,5
GO:0006026,aminoglycan catabolic process,3/81,26/13083,0.11538461538461539,18.636752136752136,7.104901876131034,5.364105015103629e-4,0.004461057032762951,0.0029144685409016003,FGF2/HMMR/HEXB,3
GO:0060421,positive regulation of heart growth,3/81,26/13083,0.11538461538461539,18.636752136752136,7.104901876131034,5.364105015103629e-4,0.004461057032762951,0.0029144685409016003,CDK1/FGF2/YAP1,3
GO:0071604,transforming growth factor beta production,3/81,26/13083,0.11538461538461539,18.636752136752136,7.104901876131034,5.364105015103629e-4,0.004461057032762951,0.0029144685409016003,TGFB2/THBS1/SMAD3,3
GO:0001656,metanephros development,4/81,62/13083,0.06451612903225806,10.420549581839904,5.868463610849445,5.790730158220852e-4,0.004799699157988425,0.003135707994543471,MYC/CTNNB1/WWTR1/YAP1,4
GO:0044843,cell cycle G1/S phase transition,7/81,233/13083,0.030042918454935622,4.852487680813861,4.683194082195721,5.898184903805748e-4,0.004872413616187356,0.003183213327771242,CDK1/LATS2/MYC/INHBA/TP63/EGFR/SMARCA2,7
GO:0000578,embryonic axis specification,3/81,27/13083,0.1111111111111111,17.946502057613166,6.957150223569752,6.007779078436474e-4,0.0048974304698805584,0.0031995571746545473,SMAD2/CTNNB1/SMAD6,3
GO:0007431,salivary gland development,3/81,27/13083,0.1111111111111111,17.946502057613166,6.957150223569752,6.007779078436474e-4,0.0048974304698805584,0.0031995571746545473,TGFB2/TGM2/EGFR,3
GO:0017145,stem cell division,3/81,27/13083,0.1111111111111111,17.946502057613166,6.957150223569752,6.007779078436474e-4,0.0048974304698805584,0.0031995571746545473,TGFB2/ETV5/WWTR1,3
GO:0033687,osteoblast proliferation,3/81,27/13083,0.1111111111111111,17.946502057613166,6.957150223569752,6.007779078436474e-4,0.0048974304698805584,0.0031995571746545473,NF2/CCN1/SMAD3,3
GO:0050767,regulation of neurogenesis,8/81,307/13083,0.026058631921824105,4.208951622632404,4.490652061764978,6.106815468781661e-4,0.0049617875683851,0.003241602532424615,NF2/FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1/YAP1,8
GO:0006935,chemotaxis,8/81,309/13083,0.025889967637540454,4.181709217307923,4.467358144236799,6.37265673187052e-4,0.005143941871803982,0.003360606388014279,CCN1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT,8
GO:0042330,taxis,8/81,309/13083,0.025889967637540454,4.181709217307923,4.467358144236799,6.37265673187052e-4,0.005143941871803982,0.003360606388014279,CCN1/SERPINE1/TGFB2/FGF2/SLIT2/THBS1/SMAD3/AMOT,8
GO:0035115,embryonic forelimb morphogenesis,3/81,28/13083,0.10714285714285714,17.305555555555557,6.817115922209003,6.698793949258199e-4,0.005389583405429234,0.00352108730471895,TP63/RUNX2/CTNNB1,3
GO:0016331,morphogenesis of embryonic epithelium,5/81,114/13083,0.043859649122807015,7.084145549057829,5.1495973961022425,6.95841484659041e-4,0.005562228048892658,0.003633878371597036,TGFB2/DLC1/TP63/CTNNB1/STK3,5
GO:0048660,regulation of smooth muscle cell proliferation,5/81,114/13083,0.043859649122807015,7.084145549057829,5.1495973961022425,6.95841484659041e-4,0.005562228048892658,0.003633878371597036,IGFBP3/FGF2/THBS1/EGFR/CTNNB1,5
GO:0003002,regionalization,8/81,314/13083,0.025477707006369428,4.115121490917669,4.409972390735549,7.078449119136581e-4,0.00563992558847334,0.0036846392188918096,ETS2/BICC1/FGF2/SMAD2/TP63/SMAD3/CTNNB1/SMAD6,8
GO:1903035,negative regulation of response to wounding,4/81,66/13083,0.06060606060606061,9.789001122334454,5.649766982512583,7.342673905645541e-4,0.005831641333422665,0.0038098896927922206,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0070306,lens fiber cell differentiation,3/81,29/13083,0.10344827586206896,16.7088122605364,6.684132419685343,7.43851760185903e-4,0.005870012292840831,0.0038349579564990396,NF2/FGF2/SMAD3,3
GO:1902742,apoptotic process involved in development,3/81,29/13083,0.10344827586206896,16.7088122605364,6.684132419685343,7.43851760185903e-4,0.005870012292840831,0.0038349579564990396,CCN1/TGFB2/SLIT2,3
GO:0002040,sprouting angiogenesis,5/81,116/13083,0.04310344827586207,6.962005108556833,5.090683350571984,7.529610731133618e-4,0.00590417095425398,0.0038572742692824856,FGF2/SLIT2/THBS1/TGM2/SMAD1,5
GO:0048754,branching morphogenesis of an epithelial tube,5/81,116/13083,0.04310344827586207,6.962005108556833,5.090683350571984,7.529610731133618e-4,0.00590417095425398,0.0038572742692824856,MYC/FGF2/SLIT2/CTNNB1/YAP1,5
GO:0014909,smooth muscle cell migration,4/81,67/13083,0.05970149253731343,9.642896627971254,5.59799428928171,7.772419502233321e-4,0.006075277269150729,0.003969060325424278,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:0046328,regulation of JNK cascade,5/81,117/13083,0.042735042735042736,6.90250079138968,5.061747501981761,7.828015595098597e-4,0.006099431709745595,0.003984840746234817,CCN2/GADD45B/GADD45A/TAOK1/STK3,5
GO:0048659,smooth muscle cell proliferation,5/81,118/13083,0.0423728813559322,6.844005021971123,5.03314943144914,8.135172452919745e-4,0.00631882891783389,0.004128175892196614,IGFBP3/FGF2/THBS1/EGFR/CTNNB1,5
GO:0009798,axis specification,4/81,68/13083,0.058823529411764705,9.501089324618738,5.547297411141763,8.219647966688982e-4,0.006364429616840685,0.0041579674419845595,ETS2/SMAD2/CTNNB1/SMAD6,4
GO:0035051,cardiocyte differentiation,5/81,119/13083,0.04201680672268908,6.786492374727669,5.004882150695685,8.451243033885967e-4,0.006523303216780731,0.00426176170096947,CDK1/INHBA/JAG1/TGFB2/EGFR,5
GO:0030162,regulation of proteolysis,10/81,490/13083,0.02040816326530612,3.2962962962962963,4.089176578781694,8.565178406247896e-4,0.006590651297019409,0.004305761107321865,RUNX1/DAB2/MYC/SERPINE1/THBS1/DLC1/SMAD7/SMAD3/USP9X/GSK3B,10
GO:0030901,midbrain development,4/81,69/13083,0.057971014492753624,9.36339237788513,5.497637723197041,8.684749710088807e-4,0.006661904280720296,0.004352311639609723,FGF2/YWHAQ/CTNNB1/SMAD1,4
GO:0043537,negative regulation of blood vessel endothelial cell migration,3/81,31/13083,0.0967741935483871,15.630824372759855,6.437031174971825,9.069414524691332e-4,0.0069354346365286665,0.004531012698827379,GADD45A/FGF2/THBS1,3
GO:0031032,actomyosin structure organization,6/81,183/13083,0.03278688524590164,5.295689131754706,4.618894426320554,9.395166399468443e-4,0.007162364508236744,0.004679269035212841,NF2/CCN2/DLC1/ITGB5/SMAD3/AMOT,6
GO:0001666,response to hypoxia,7/81,253/13083,0.02766798418972332,4.468891816717903,4.397564208012973,9.57924431912225e-4,0.00728022568253291,0.004756269325089688,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0007422,peripheral nervous system development,4/81,71/13083,0.056338028169014086,9.09963484611372,5.401284933292276,9.670136288556985e-4,0.007326759703293176,0.004786670626528208,RUNX1/CDK1/PMP22/NDRG1,4
GO:0032970,regulation of actin filament-based process,8/81,330/13083,0.024242424242424242,3.9156004489337826,4.2340238447743035,9.772429135497145e-4,0.007341086407234968,0.004796030454843898,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT/FRMD6,8
GO:0010563,negative regulation of phosphorus metabolic process,7/81,254/13083,0.027559055118110236,4.451297754447361,4.3840690484359985,9.8022170669851e-4,0.007341086407234968,0.004796030454843898,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:0045936,negative regulation of phosphate metabolic process,7/81,254/13083,0.027559055118110236,4.451297754447361,4.3840690484359985,9.8022170669851e-4,0.007341086407234968,0.004796030454843898,IGFBP3/LATS2/INHBA/GADD45A/SLIT2/SMAD7/WWTR1,7
GO:2001235,positive regulation of apoptotic signaling pathway,5/81,123/13083,0.04065040650406504,6.565793435712135,4.894988098206736,9.80792920804672e-4,0.007341086407234968,0.004796030454843898,MYC/INHBA/THBS1/TP63/STK3,5
GO:0032388,positive regulation of intracellular transport,5/81,124/13083,0.04032258064516129,6.51284348864994,4.8682767798192605,0.0010171026060225936,0.007582009637840095,0.004953428840745308,NF2/CDK1/DAB2/SMAD3/GSK3B,5
GO:0048704,embryonic skeletal system morphogenesis,4/81,72/13083,0.05555555555555555,8.973251028806583,5.354523739223245,0.0010191203237906524,0.007582009637840095,0.004953428840745308,SMAD2/SMAD3/RUNX2/CTNNB1,4
GO:0035136,forelimb morphogenesis,3/81,33/13083,0.09090909090909091,14.683501683501685,6.2118858290959436,0.0010910824332359113,0.008056694628095808,0.005263546927283561,TP63/RUNX2/CTNNB1,3
GO:0060251,regulation of glial cell proliferation,3/81,33/13083,0.09090909090909091,14.683501683501685,6.2118858290959436,0.0010910824332359113,0.008056694628095808,0.005263546927283561,NF2/ETV5/EGFR,3
GO:0030177,positive regulation of Wnt signaling pathway,5/81,126/13083,0.03968253968253968,6.409465020576131,4.815727020958134,0.0010927095953085406,0.008056694628095808,0.005263546927283561,DAB2/FGF2/SMAD3/EGFR/YAP1,5
GO:1903829,positive regulation of protein localization,9/81,419/13083,0.021479713603818614,3.469371519490851,4.054921923919287,0.0011034480021904632,0.008111656444673942,0.005299454221046304,NF2/AMOTL2/CDK1/TGFB2/SMAD3/GSK3B/EGFR/WWTR1/YAP1,9
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,4/81,74/13083,0.05405405405405406,8.730730730730732,5.263673596921144,0.001129204011761174,0.008251875470562425,0.005391061195982185,SERPINE1/THBS1/GSK3B/STK3,4
GO:0045638,negative regulation of myeloid cell differentiation,4/81,74/13083,0.05405405405405406,8.730730730730732,5.263673596921144,0.001129204011761174,0.008251875470562425,0.005391061195982185,RUNX1/MYC/INHBA/CTNNB1,4
GO:0060412,ventricular septum morphogenesis,3/81,34/13083,0.08823529411764706,14.251633986928105,6.106533950766834,0.0011913581489413924,0.008680397132404835,0.005671020159376355,TGFB2/SLIT2/SMAD7,3
GO:0007009,plasma membrane organization,5/81,129/13083,0.03875968992248062,6.260407694516221,4.739001150381478,0.0012138418994138058,0.008818204386917942,0.005761051491645091,ASAP1/MYOF/CAVIN2/NDRG1/TGFB2,5
GO:0060993,kidney morphogenesis,4/81,76/13083,0.05263157894736842,8.500974658869396,5.176192572739424,0.001247375389670562,0.009035241092335156,0.005902844489473597,MYC/FGF2/CTNNB1/WWTR1,4
GO:0048592,eye morphogenesis,5/81,130/13083,0.038461538461538464,6.212250712250713,4.713964327678708,0.0012563464086994326,0.009047159269643144,0.00591063079495544,JAG1/FJX1/FGF2/FAT1/CTNNB1,5
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,5/81,130/13083,0.038461538461538464,6.212250712250713,4.713964327678708,0.0012563464086994326,0.009047159269643144,0.00591063079495544,TET1/CRIM1/SMAD7/UBE2D1/SMAD6,5
GO:0036293,response to decreased oxygen levels,7/81,266/13083,0.02631578947368421,4.250487329434698,4.227373344175034,0.0012811173544339401,0.009198720539104163,0.006009647810120044,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0060391,positive regulation of SMAD protein signal transduction,3/81,35/13083,0.08571428571428572,13.844444444444445,6.005537370532252,0.0012972642396526912,0.009253196291704532,0.006045237551750713,DAB2/INHBA/TGFB2,3
GO:1990776,response to angiotensin,3/81,35/13083,0.08571428571428572,13.844444444444445,6.005537370532252,0.0012972642396526912,0.009253196291704532,0.006045237551750713,INHBA/SMAD3/FAT1,3
GO:0048639,positive regulation of developmental growth,5/81,131/13083,0.03816793893129771,6.164828951088493,4.6891883146233715,0.00129994296081841,0.009253196291704532,0.006045237551750713,CDK1/FGF2/SMAD7/CREB1/YAP1,5
GO:2001234,negative regulation of apoptotic signaling pathway,6/81,196/13083,0.030612244897959183,4.944444444444445,4.391495742248578,0.001338333590683776,0.009499091864910708,0.006205884435929307,SERPINE1/FGF2/THBS1/GSK3B/CTNNB1/YAP1,6
GO:0021915,neural tube development,5/81,133/13083,0.03759398496240601,6.072124756335282,4.640399425723587,0.0013904810687767534,0.009812823542510231,0.006410849559202295,MARCKS/TGFB2/PHGDH/DLC1/STK3,5
GO:0030307,positive regulation of cell growth,5/81,133/13083,0.03759398496240601,6.072124756335282,4.640399425723587,0.0013904810687767534,0.009812823542510231,0.006410849559202295,TGFB2/SMAD7/TEAD1/EGFR/YAP1,5
GO:0022602,ovulation cycle process,3/81,36/13083,0.08333333333333333,13.459876543209877,5.908594139541882,0.0014089174127348183,0.009830581947612998,0.006422451364027585,INHBA/TGFB2/SLIT2,3
GO:0032570,response to progesterone,3/81,36/13083,0.08333333333333333,13.459876543209877,5.908594139541882,0.0014089174127348183,0.009830581947612998,0.006422451364027585,TGFB2/THBS1/YAP1,3
GO:0035272,exocrine system development,3/81,36/13083,0.08333333333333333,13.459876543209877,5.908594139541882,0.0014089174127348183,0.009830581947612998,0.006422451364027585,TGFB2/TGM2/EGFR,3
GO:0046622,positive regulation of organ growth,3/81,36/13083,0.08333333333333333,13.459876543209877,5.908594139541882,0.0014089174127348183,0.009830581947612998,0.006422451364027585,CDK1/FGF2/YAP1,3
GO:0045995,regulation of embryonic development,4/81,79/13083,0.05063291139240506,8.178152836380685,5.050824370105964,0.0014404799540099808,0.010022494327900429,0.0065478303024382525,CDK1/JAG1/AMOT/CTNNB1,4
GO:0001667,ameboidal-type cell migration,6/81,199/13083,0.03015075376884422,4.869905080960358,4.341861782239177,0.0014464253260635372,0.010030585780487787,0.006553116557207662,AMOTL2/TGFB2/FGF2/THBS1/AMOTL1/AMOT,6
GO:0045859,regulation of protein kinase activity,8/81,351/13083,0.022792022792022793,3.6813337554078296,4.019116729265559,0.0014497648273822429,0.010030585780487787,0.006553116557207662,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/EGFR/WWTR1,8
GO:0014812,muscle cell migration,4/81,80/13083,0.05,8.075925925925928,5.010499130168284,0.0015092298964208526,0.010412843140110352,0.006802850429912283,IGFBP3/SERPINE1/SLIT2/FAT1,4
GO:0001825,blastocyst formation,3/81,37/13083,0.08108108108108109,13.096096096096096,5.815430961234773,0.0015264316487351515,0.010415155172308906,0.00680436091163416,TET1/LATS2/YAP1,3
GO:0032872,regulation of stress-activated MAPK cascade,3/81,37/13083,0.08108108108108109,13.096096096096096,5.815430961234773,0.0015264316487351515,0.010415155172308906,0.00680436091163416,MYC/TGFB2/TAOK1,3
GO:0048701,embryonic cranial skeleton morphogenesis,3/81,37/13083,0.08108108108108109,13.096096096096096,5.815430961234773,0.0015264316487351515,0.010415155172308906,0.00680436091163416,SMAD2/SMAD3/RUNX2,3
GO:0060428,lung epithelium development,3/81,37/13083,0.08108108108108109,13.096096096096096,5.815430961234773,0.0015264316487351515,0.010415155172308906,0.00680436091163416,CTNNB1/CREB1/YAP1,3
GO:0045786,negative regulation of cell cycle,8/81,355/13083,0.022535211267605635,3.6398539384454875,3.980049674405028,0.0015575404830380753,0.01059294831982547,0.006920515565434666,CDK1/LATS2/ETS1/CENPF/INHBA/TAOK1/EGFR/CTNNB1,8
GO:0001933,negative regulation of protein phosphorylation,6/81,202/13083,0.0297029702970297,4.7975797579757975,4.2932116522661685,0.001561066068184806,0.01059294831982547,0.006920515565434666,IGFBP3/LATS2/GADD45A/SLIT2/SMAD7/WWTR1,6
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,4/81,81/13083,0.04938271604938271,7.976223136716963,4.970868710130019,0.0015802354290584111,0.010693647971984317,0.006986304002152976,SERPINE1/THBS1/GSK3B/YAP1,4
GO:0033689,negative regulation of osteoblast proliferation,2/81,10/13083,0.2,32.30370370370371,7.81596479625077,0.0016497245613885615,0.010984630844175291,0.007176407024982196,NF2/SMAD3,2
GO:0060413,atrial septum morphogenesis,2/81,10/13083,0.2,32.30370370370371,7.81596479625077,0.0016497245613885615,0.010984630844175291,0.007176407024982196,CCN1/TGFB2,2
GO:0062042,regulation of cardiac epithelial to mesenchymal transition,2/81,10/13083,0.2,32.30370370370371,7.81596479625077,0.0016497245613885615,0.010984630844175291,0.007176407024982196,JAG1/TGFB2,2
GO:1901329,regulation of odontoblast differentiation,2/81,10/13083,0.2,32.30370370370371,7.81596479625077,0.0016497245613885615,0.010984630844175291,0.007176407024982196,SERPINE1/CTNNB1,2
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/81,10/13083,0.2,32.30370370370371,7.81596479625077,0.0016497245613885615,0.010984630844175291,0.007176407024982196,THBS1/STK3,2
GO:0043114,regulation of vascular permeability,3/81,38/13083,0.07894736842105263,12.751461988304092,5.725799782475944,0.0016499182361089202,0.010984630844175291,0.007176407024982196,DDAH1/SLIT2/AMOT,3
GO:0050769,positive regulation of neurogenesis,6/81,205/13083,0.02926829268292683,4.727371273712738,4.245510066613181,0.0016825126117049325,0.011171521911051568,0.007298505471827,FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1,6
GO:0070372,regulation of ERK1 and ERK2 cascade,6/81,206/13083,0.02912621359223301,4.704422869471413,4.229814483907057,0.0017245520816792307,0.011419956144095711,0.007460810896611432,CCN2/DAB2/CCN1/INHBA/FGF2/EGFR,6
GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,5/81,140/13083,0.03571428571428571,5.768518518518518,4.477179605525451,0.001744312165438015,0.011519922589924859,0.007526120319776182,TGFB2/FGF2/THBS1/EGFR/STK3,5
GO:0010719,negative regulation of epithelial to mesenchymal transition,3/81,39/13083,0.07692307692307693,12.424501424501425,5.639474867972344,0.0017794858055950468,0.01165870010562272,0.007616785536722621,TGFB2/SMAD7/GSK3B,3
GO:0031638,zymogen activation,3/81,39/13083,0.07692307692307693,12.424501424501425,5.639474867972344,0.0017794858055950468,0.01165870010562272,0.007616785536722621,RUNX1/SERPINE1/THBS1,3
GO:0070302,regulation of stress-activated protein kinase signaling cascade,3/81,39/13083,0.07692307692307693,12.424501424501425,5.639474867972344,0.0017794858055950468,0.01165870010562272,0.007616785536722621,MYC/TGFB2/TAOK1,3
GO:0018105,peptidyl-serine phosphorylation,5/81,141/13083,0.03546099290780142,5.727607039663778,4.454764296122353,0.0017997849916016053,0.011746619521840073,0.007674224473462959,CDK1/GADD45A/SMAD7/GSK3B/EGFR,5
GO:0014013,regulation of gliogenesis,4/81,84/13083,0.047619047619047616,7.691358024691358,4.855941429428788,0.001807172234129242,0.011746619521840073,0.007674224473462959,NF2/ETV5/EGFR/CTNNB1,4
GO:1900182,positive regulation of protein localization to nucleus,4/81,84/13083,0.047619047619047616,7.691358024691358,4.855941429428788,0.001807172234129242,0.011746619521840073,0.007674224473462959,CDK1/SMAD3/WWTR1/YAP1,4
GO:0051960,regulation of nervous system development,8/81,365/13083,0.021917808219178082,3.5401319127346524,3.88479220507344,0.0018550267401805788,0.011997465522338296,0.007838105538352699,NF2/FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1/YAP1,8
GO:0000082,G1/S transition of mitotic cell cycle,6/81,209/13083,0.028708133971291867,4.636895268474215,4.18332577590168,0.0018554784734952344,0.011997465522338296,0.007838105538352699,CDK1/LATS2/MYC/INHBA/EGFR/SMARCA2,6
GO:0008593,regulation of Notch signaling pathway,4/81,85/13083,0.047058823529411764,7.6008714596949885,4.818889560570848,0.0018875863155853165,0.012173206787195122,0.007952919669622896,JAG1/TGFB2/TP63/YAP1,4
GO:0003197,endocardial cushion development,3/81,40/13083,0.075,12.113888888888887,5.556250278998321,0.0019152403642454488,0.012319384634599632,0.008048419622774873,JAG1/TGFB2/SMAD2,3
GO:0010944,negative regulation of transcription by competitive promoter binding,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,SMAD7/CREB1,2
GO:0018149,peptide cross-linking,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,THBS1/TGM2,2
GO:0051917,regulation of fibrinolysis,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,SERPINE1/THBS1,2
GO:0061101,neuroendocrine cell differentiation,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,JAG1/FGF2,2
GO:0072497,mesenchymal stem cell differentiation,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,GSK3B/CTNNB1,2
GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2/81,11/13083,0.18181818181818182,29.36700336700337,7.428707936924653,0.0020082411033273267,0.01271886032107307,0.008309402459921166,FGF2/CTNNB1,2
GO:0002683,negative regulation of immune system process,8/81,370/13083,0.021621621621621623,3.492292292292292,3.83840073603056,0.0020197647427151757,0.012759127658584358,0.008335709652934082,RUNX1/MYC/INHBA/TGFB2/SLIT2/THBS1/SMAD7/CTNNB1,8
GO:0010638,positive regulation of organelle organization,9/81,458/13083,0.019650655021834062,3.1739446870451236,3.7380063643255173,0.0020390283783043267,0.012799734919153188,0.008362238922250943,ASAP1/NF2/CDK1/CCN2/MYC/SMAD3/GSK3B/AMOT/CTNNB1,9
GO:0060840,artery development,4/81,87/13083,0.04597701149425287,7.4261387824606215,4.746564388084272,0.002055797199799994,0.012799734919153188,0.008362238922250943,JAG1/TGFB2/SMAD7/SMAD6,4
GO:0097306,cellular response to alcohol,4/81,87/13083,0.04597701149425287,7.4261387824606215,4.746564388084272,0.002055797199799994,0.012799734919153188,0.008362238922250943,INHBA/SGK1/CTNNB1/CREB1,4
GO:0070482,response to oxygen levels,7/81,289/13083,0.02422145328719723,3.912213251313597,3.9513311013383197,0.0020569057751953787,0.012799734919153188,0.008362238922250943,MYC/INHBA/NDRG1/TGFB2/DDAH1/THBS1/SMAD3,7
GO:0035315,hair cell differentiation,3/81,41/13083,0.07317073170731707,11.818428184281842,5.475937691988549,0.0020572853291108565,0.012799734919153188,0.008362238922250943,JAG1/FGF2/CTNNB1,3
GO:0045620,negative regulation of lymphocyte differentiation,3/81,41/13083,0.07317073170731707,11.818428184281842,5.475937691988549,0.0020572853291108565,0.012799734919153188,0.008362238922250943,RUNX1/INHBA/SMAD7,3
GO:0071396,cellular response to lipid,9/81,461/13083,0.019522776572668113,3.153289949385394,3.7150391007676213,0.002131450306180765,0.01322784486499118,0.008641928906043676,DAB2/INHBA/SERPINE1/SGK1/TP63/GSK3B/EGFR/CREB1/YAP1,9
GO:0010001,glial cell differentiation,6/81,215/13083,0.027906976744186046,4.50749354005168,4.092937233624624,0.002139853663981765,0.013246713157982357,0.008654255815549522,CDK1/NDRG1/FGF2/PHGDH/EGFR/CTNNB1,6
GO:0003208,cardiac ventricle morphogenesis,3/81,42/13083,0.07142857142857142,11.537037037037036,5.398364504127138,0.002205721560586125,0.013552567797631167,0.008854074764018146,JAG1/TGFB2/SMAD7,3
GO:0035196,miRNA processing,3/81,42/13083,0.07142857142857142,11.537037037037036,5.398364504127138,0.002205721560586125,0.013552567797631167,0.008854074764018146,SMAD2/SMAD3/SMAD1,3
GO:0042181,ketone biosynthetic process,3/81,42/13083,0.07142857142857142,11.537037037037036,5.398364504127138,0.002205721560586125,0.013552567797631167,0.008854074764018146,DAB2/INHBA/CREB1,3
GO:0030010,establishment of cell polarity,5/81,148/13083,0.033783783783783786,5.456706706706707,4.303642587588514,0.002225055195469723,0.01363743506900798,0.0089095196934963709,AMOTL2/AMOTL1/GSK3B/AMOT/FAT1,5
GO:0044057,regulation of system process,8/81,376/13083,0.02127659574468085,3.4365642237982663,3.783770366832337,0.002232497234020405,0.013649178633738613,0.008917191922233668,DAB2/INHBA/TGFB2/GLS/SGK1/SMAD7/SMAD3/EGFR,8
GO:0043549,regulation of kinase activity,8/81,377/13083,0.021220159151193633,3.427448668827979,3.774772701221316,0.002269608870980352,0.013841812126719678,0.009043041973262845,LATS2/CCN1/GADD45A/TGFB2/FGF2/THBS1/EGFR/WWTR1,8
GO:0045930,negative regulation of mitotic cell cycle,6/81,218/13083,0.027522935779816515,4.445463812436289,4.048979196748538,0.0022938408297854865,0.013955140023571802,0.00911708061203306,CDK1/CENPF/INHBA/TAOK1/EGFR/CTNNB1,6
GO:0002076,osteoblast development,2/81,12/13083,0.16666666666666666,26.919753086419753,7.089923950399112,0.0024002259543334024,0.014495252095852089,0.009469943090961538,SMAD3/RUNX2,2
GO:0060039,pericardium development,2/81,12/13083,0.16666666666666666,26.919753086419753,7.089923950399112,0.0024002259543334024,0.014495252095852089,0.009469943090961538,SMAD2/SMAD3,2
GO:0061029,eyelid development in camera-type eye,2/81,12/13083,0.16666666666666666,26.919753086419753,7.089923950399112,0.0024002259543334024,0.014495252095852089,0.009469943090961538,INHBA/EGFR,2
GO:0018209,peptidyl-serine modification,5/81,151/13083,0.033112582781456956,5.348295315182733,4.241789944689449,0.002428098183132469,0.014627811005700483,0.009556545609093903,CDK1/GADD45A/SMAD7/GSK3B/EGFR,5
GO:0032956,regulation of actin cytoskeleton organization,7/81,299/13083,0.023411371237458192,3.7813699987613028,3.840037628079322,0.002490553575602566,0.014967560417854839,0.009778508468174501,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT,7
GO:0090263,positive regulation of canonical Wnt signaling pathway,4/81,92/13083,0.043478260869565216,7.022544283413849,4.5753795348159665,0.0025211629376471023,0.01504766168615201,0.00983083970375923,FGF2/SMAD3/EGFR/YAP1,4
GO:0001658,branching involved in ureteric bud morphogenesis,3/81,44/13083,0.06818181818181818,11.012626262626263,5.250814819507803,0.002522158679379325,0.01504766168615201,0.00983083970375923,MYC/FGF2/CTNNB1,3
GO:0035987,endodermal cell differentiation,3/81,44/13083,0.06818181818181818,11.012626262626263,5.250814819507803,0.002522158679379325,0.01504766168615201,0.00983083970375923,INHBA/ITGB5/CTNNB1,3
GO:0021795,cerebral cortex cell migration,3/81,45/13083,0.06666666666666667,10.767901234567901,5.18055786797896,0.002690348799609306,0.015973945997680254,0.010435993698889338,SLIT2/EGFR/CTNNB1,3
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,3/81,45/13083,0.06666666666666667,10.767901234567901,5.18055786797896,0.002690348799609306,0.015973945997680254,0.010435993698889338,INHBA/THBS1/STK3,3
GO:0050920,regulation of chemotaxis,5/81,155/13083,0.03225806451612903,5.210274790919952,4.16183750990572,0.0027193965103345964,0.016107696356178543,0.010523374606444369,SERPINE1/FGF2/SLIT2/THBS1/SMAD3,5
GO:0048144,fibroblast proliferation,4/81,94/13083,0.0425531914893617,6.873128447596533,4.5104520319838075,0.002726034704060934,0.016108386887632793,0.010523825739928008,CDK1/MYC/EGFR/CTNNB1,4
GO:0003215,cardiac right ventricle morphogenesis,2/81,13/13083,0.15384615384615385,24.84900284900285,6.790138125349007,0.0028252612942687985,0.016501417961998426,0.010780598225332874,JAG1/TGFB2,2
GO:0034333,adherens junction assembly,2/81,13/13083,0.15384615384615385,24.84900284900285,6.790138125349007,0.0028252612942687985,0.016501417961998426,0.010780598225332874,SMAD7/CTNNB1,2
GO:0038092,nodal signaling pathway,2/81,13/13083,0.15384615384615385,24.84900284900285,6.790138125349007,0.0028252612942687985,0.016501417961998426,0.010780598225332874,SMAD2/SMAD3,2
GO:0048820,hair follicle maturation,2/81,13/13083,0.15384615384615385,24.84900284900285,6.790138125349007,0.0028252612942687985,0.016501417961998426,0.010780598225332874,TGFB2/CTNNB1,2
GO:0001838,embryonic epithelial tube formation,4/81,95/13083,0.042105263157894736,6.800779727095516,4.478695516289701,0.002832632071209446,0.016501417961998426,0.010780598225332874,TGFB2/DLC1/CTNNB1/STK3,4
GO:0030216,keratinocyte differentiation,4/81,95/13083,0.042105263157894736,6.800779727095516,4.478695516289701,0.002832632071209446,0.016501417961998426,0.010780598225332874,LATS2/JAG1/TP63/YAP1,4
GO:0010595,positive regulation of endothelial cell migration,4/81,96/13083,0.041666666666666664,6.729938271604938,4.447394356053182,0.002942052864055999,0.01709851899816075,0.011170692360613863,ETS1/FGF2/THBS1/AMOT,4
GO:0014009,glial cell proliferation,3/81,47/13083,0.06382978723404255,10.309692671394798,5.046457248993065,0.003047126996025518,0.01758555752697679,0.011488881179993787,NF2/ETV5/EGFR,3
GO:0030858,positive regulation of epithelial cell differentiation,3/81,47/13083,0.06382978723404255,10.309692671394798,5.046457248993065,0.003047126996025518,0.01758555752697679,0.011488881179993787,SERPINE1/FGF2/CTNNB1,3
GO:0046887,positive regulation of hormone secretion,4/81,97/13083,0.041237113402061855,6.660557464681175,4.4165369931441845,0.003054333675738074,0.01758555752697679,0.011488881179993787,DAB2/INHBA/EGFR/CREB1,4
GO:0061041,regulation of wound healing,4/81,97/13083,0.041237113402061855,6.660557464681175,4.4165369931441845,0.003054333675738074,0.01758555752697679,0.011488881179993787,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0009410,response to xenobiotic stimulus,7/81,313/13083,0.022364217252396165,3.6122352384333216,3.6920154080243996,0.003212496201385765,0.01845317585447172,0.012055707898958086,CDK1/CENPF/MYC/THBS1/EGFR/CTNNB1/CREB1,7
GO:0001738,morphogenesis of a polarized epithelium,3/81,48/13083,0.0625,10.094907407407407,4.982391889364625,0.003235889839822291,0.01853977911480893,0.012112286973365477,TP63/FAT1/YAP1,3
GO:0021537,telencephalon development,6/81,234/13083,0.02564102564102564,4.1415004748338085,3.8272329310054074,0.003260877827911831,0.01853977911480893,0.012112286973365477,NF2/INHBA/SLIT2/GSK3B/EGFR/CTNNB1,6
GO:0110053,regulation of actin filament organization,6/81,234/13083,0.02564102564102564,4.1415004748338085,3.8272329310054074,0.003260877827911831,0.01853977911480893,0.012112286973365477,NF2/CCN2/SLIT2/DLC1/SMAD3/AMOT,6
GO:0048485,sympathetic nervous system development,2/81,14/13083,0.14285714285714285,23.074074074074073,6.522285953038096,0.0032829330828068604,0.01853977911480893,0.012112286973365477,TP63/CTNNB1,2
GO:0051895,negative regulation of focal adhesion assembly,2/81,14/13083,0.14285714285714285,23.074074074074073,6.522285953038096,0.0032829330828068604,0.01853977911480893,0.012112286973365477,THBS1/DLC1,2
GO:0071636,positive regulation of transforming growth factor beta production,2/81,14/13083,0.14285714285714285,23.074074074074073,6.522285953038096,0.0032829330828068604,0.01853977911480893,0.012112286973365477,THBS1/SMAD3,2
GO:0150118,negative regulation of cell-substrate junction organization,2/81,14/13083,0.14285714285714285,23.074074074074073,6.522285953038096,0.0032829330828068604,0.01853977911480893,0.012112286973365477,THBS1/DLC1,2
GO:0048706,embryonic skeletal system development,4/81,99/13083,0.04040404040404041,6.5260007482229705,4.356109461189418,0.003287620749913486,0.01853977911480893,0.012112286973365477,SMAD2/SMAD3/RUNX2/CTNNB1,4
GO:0051962,positive regulation of nervous system development,6/81,236/13083,0.025423728813559324,4.106403013182675,3.8009087129778236,0.0034003288388494974,0.019131690733390112,0.012498990792366094,FGF2/SLIT2/ETV5/TGM2/EGFR/CTNNB1,6
GO:0048645,animal organ formation,3/81,49/13083,0.061224489795918366,9.88888888888889,4.920181913756349,0.003431681117518773,0.01922505532561907,0.01255998713580824,FGF2/TP63/CTNNB1,3
GO:0031401,positive regulation of protein modification process,9/81,495/13083,0.01818181818181818,2.9367003367003366,3.4670584343784046,0.003432489635059923,0.01922505532561907,0.01255998713580824,DAB2/CCN1/TGFB2/FGF2/THBS1/UBE2D1/TAOK1/GSK3B/EGFR,9
GO:0007623,circadian rhythm,5/81,164/13083,0.03048780487804878,4.9243450767841015,3.9916197684968346,0.003466433164635661,0.01937124415531693,0.012655494263840125,CDK1/USP9X/GSK3B/EGFR/CREB1,5
GO:0032870,cellular response to hormone stimulus,9/81,496/13083,0.018145161290322582,2.9307795698924735,3.460086196413467,0.0034785543905711557,0.019395100100927213,0.012671079673863803,LATS2/DAB2/INHBA/SLIT2/SGK1/TP63/GSK3B/FAT1/EGFR,9
GO:0045446,endothelial cell differentiation,4/81,101/13083,0.039603960396039604,6.396773010634397,4.2973283392846575,0.0035327820457010024,0.019653089308291613,0.012839627491843617,AMOTL2/JAG1/FSTL1/CTNNB1,4
GO:0051348,negative regulation of transferase activity,5/81,165/13083,0.030303030303030304,4.894500561167227,3.9734760873132116,0.003557690336993826,0.019747180072752248,0.012901098253368506,LATS2/GADD45A/SMAD7/GSK3B/WWTR1,5
GO:0002042,cell migration involved in sprouting angiogenesis,3/81,50/13083,0.06,9.69111111111111,4.859735221009378,0.0036345823968209293,0.020083710335900885,0.013120957999120417,FGF2/SLIT2/THBS1,3
GO:0071300,cellular response to retinoic acid,3/81,50/13083,0.06,9.69111111111111,4.859735221009378,0.0036345823968209293,0.020083710335900885,0.013120957999120417,GSK3B/CREB1/YAP1,3
GO:0022612,gland morphogenesis,4/81,102/13083,0.0392156862745098,6.334059549745824,4.2685303313061045,0.003659904841583876,0.0201784932114111,0.013182880926099818,TGFB2/TGM2/TP63/EGFR,4
GO:0021543,pallium development,5/81,167/13083,0.029940119760479042,4.835883787979596,3.937623240914418,0.003745373860025594,0.02039144998483927,0.013322008449502919,NF2/SLIT2/GSK3B/EGFR/CTNNB1,5
GO:0032386,regulation of intracellular transport,6/81,241/13083,0.024896265560165973,4.021207929921623,3.7363478812413944,0.00376842589487832,0.02039144998483927,0.013322008449502919,NF2/PTPN14/CDK1/DAB2/SMAD3/GSK3B,6
GO:0001759,organ induction,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,FGF2/CTNNB1,2
GO:0032926,negative regulation of activin receptor signaling pathway,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,SMAD7/SMAD6,2
GO:0034616,response to laminar fluid shear stress,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,SMAD7/SMAD6,2
GO:0042730,fibrinolysis,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,SERPINE1/THBS1,2
GO:0048368,lateral mesoderm development,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,SMAD2/YAP1,2
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,FGF2/THBS1,2
GO:2000738,positive regulation of stem cell differentiation,2/81,15/13083,0.13333333333333333,21.535802469135803,6.280977618921929,0.003772831029583622,0.02039144998483927,0.013322008449502919,TGFB2/FGF2,2
GO:0001824,blastocyst development,4/81,103/13083,0.038834951456310676,6.272563825961884,4.240114777079858,0.003790102932907255,0.02041377451352283,0.01333659336425762,TET1/GINS1/LATS2/YAP1,4
GO:0044772,mitotic cell cycle phase transition,8/81,410/13083,0.01951219512195122,3.151580849141825,3.4936901219239807,0.0037934908913793437,0.02041377451352283,0.01333659336425762,CDK1/LATS2/CENPF/MYC/INHBA/TAOK1/EGFR/SMARCA2,8
GO:0051403,stress-activated MAPK cascade,3/81,51/13083,0.058823529411764705,9.501089324618738,4.800966028289906,0.003844672974054326,0.020599440880507993,0.013457891698196785,MYC/TGFB2/TAOK1,3
GO:0060675,ureteric bud morphogenesis,3/81,51/13083,0.058823529411764705,9.501089324618738,4.800966028289906,0.003844672974054326,0.020599440880507993,0.013457891698196785,MYC/FGF2/CTNNB1,3
GO:0030326,embryonic limb morphogenesis,4/81,104/13083,0.038461538461538464,6.212250712250713,4.212072635147112,0.003923411434564873,0.020930510244870918,0.013674183765347167,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0035113,embryonic appendage morphogenesis,4/81,104/13083,0.038461538461538464,6.212250712250713,4.212072635147112,0.003923411434564873,0.020930510244870918,0.013674183765347167,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0072593,reactive oxygen species metabolic process,5/81,170/13083,0.029411764705882353,4.750544662309369,3.8848989571835775,0.004040093203011908,0.021484397994727115,0.014036046079657648,CCN2/CCN1/GADD45A/THBS1/EGFR,5
GO:0022029,telencephalon cell migration,3/81,52/13083,0.057692307692307696,9.318376068376068,4.743794323263742,0.00406202990426622,0.021484397994727115,0.014036046079657648,SLIT2/EGFR/CTNNB1,3
GO:0035904,aorta development,3/81,52/13083,0.057692307692307696,9.318376068376068,4.743794323263742,0.00406202990426622,0.021484397994727115,0.014036046079657648,JAG1/TGFB2/SMAD6,3
GO:0072171,mesonephric tubule morphogenesis,3/81,52/13083,0.057692307692307696,9.318376068376068,4.743794323263742,0.00406202990426622,0.021484397994727115,0.014036046079657648,MYC/FGF2/CTNNB1,3
GO:0021536,diencephalon development,3/81,53/13083,0.05660377358490566,9.142557651991615,4.688145373286828,0.004286728031019051,0.022473591005254492,0.014682299173686401,FGF2/CTNNB1/CREB1,3
GO:0035019,somatic stem cell population maintenance,3/81,53/13083,0.05660377358490566,9.142557651991615,4.688145373286828,0.004286728031019051,0.022473591005254492,0.014682299173686401,MYC/TP63/YAP1,3
GO:0070918,regulatory ncRNA processing,3/81,53/13083,0.05660377358490566,9.142557651991615,4.688145373286828,0.004286728031019051,0.022473591005254492,0.014682299173686401,SMAD2/SMAD3/SMAD1,3
GO:0043586,tongue development,2/81,16/13083,0.125,20.189814814814813,6.062019520214146,0.00429454856456685,0.022473591005254492,0.014682299173686401,EGFR/CTNNB1,2
GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2/81,16/13083,0.125,20.189814814814813,6.062019520214146,0.00429454856456685,0.022473591005254492,0.014682299173686401,FGF2/CTNNB1,2
GO:0048593,camera-type eye morphogenesis,4/81,107/13083,0.037383177570093455,6.038075458636206,4.130100686532395,0.004342347039338367,0.02267568115679866,0.014814327386904901,JAG1/FJX1/FAT1/CTNNB1,4
GO:0010811,positive regulation of cell-substrate adhesion,4/81,108/13083,0.037037037037037035,5.982167352537723,4.103467584056051,0.004488443616448059,0.023389147115246214,0.015280444290506054,DAB2/CCN1/SMAD3/GSK3B,4
GO:0021885,forebrain cell migration,3/81,54/13083,0.05555555555555555,8.973251028806583,4.633949284725117,0.004518840015877879,0.02339944410737602,0.01528717145391325,SLIT2/EGFR/CTNNB1,3
GO:0031098,stress-activated protein kinase signaling cascade,3/81,54/13083,0.05555555555555555,8.973251028806583,4.633949284725117,0.004518840015877879,0.02339944410737602,0.01528717145391325,MYC/TGFB2/TAOK1,3
GO:0070613,regulation of protein processing,3/81,54/13083,0.05555555555555555,8.973251028806583,4.633949284725117,0.004518840015877879,0.02339944410737602,0.01528717145391325,RUNX1/SERPINE1/THBS1,3
GO:0046822,regulation of nucleocytoplasmic transport,4/81,109/13083,0.03669724770642202,5.927285083248386,4.077166935856278,0.00463782260121258,0.023965317625512707,0.015656864231796713,PTPN14/CDK1/SMAD3/GSK3B,4
GO:0009612,response to mechanical stimulus,5/81,176/13083,0.028409090909090908,4.588594276094276,3.783053994900762,0.0046788145129298755,0.02412666356354236,0.01576227370249753,GADD45A/FGF2/THBS1/EGFR/CTNNB1,5
GO:0008347,glial cell migration,3/81,55/13083,0.05454545454545454,8.81010101010101,4.581140606459805,0.004758436367594715,0.024384518315267518,0.01593073367880039,TGFB2/HEXB/CTNNB1,3
GO:0051058,negative regulation of small GTPase mediated signal transduction,3/81,55/13083,0.05454545454545454,8.81010101010101,4.581140606459805,0.004758436367594715,0.024384518315267518,0.01593073367880039,TGFB2/SLIT2/DLC1,3
GO:2000379,positive regulation of reactive oxygen species metabolic process,3/81,55/13083,0.05454545454545454,8.81010101010101,4.581140606459805,0.004758436367594715,0.024384518315267518,0.01593073367880039,GADD45A/THBS1/EGFR,3
GO:0043086,negative regulation of catalytic activity,7/81,337/13083,0.020771513353115726,3.354984064182877,3.456929056721276,0.004811122749730427,0.024486250587615055,0.015997196740172123,LATS2/GADD45A/SERPINE1/THBS1/SMAD7/GSK3B/WWTR1,7
GO:0003283,atrial septum development,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,CCN1/TGFB2,2
GO:0023019,signal transduction involved in regulation of gene expression,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,SMAD2/SMAD3,2
GO:0033137,negative regulation of peptidyl-serine phosphorylation,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,GADD45A/SMAD7,2
GO:0062009,secondary palate development,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,TGFB2/SMAD2,2
GO:0072234,metanephric nephron tubule development,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,WWTR1/YAP1,2
GO:2001026,regulation of endothelial cell chemotaxis,2/81,17/13083,0.11764705882352941,19.002178649237475,5.862092971437585,0.0048476828086412,0.024486250587615055,0.015997196740172123,FGF2/THBS1,2
GO:0009799,specification of symmetry,4/81,111/13083,0.036036036036036036,5.820487153820487,4.025533547094786,0.004946562142052299,0.02488392767997796,0.016257004531602906,BICC1/SMAD2/SMAD3/CTNNB1,4
GO:0009855,determination of bilateral symmetry,4/81,111/13083,0.036036036036036036,5.820487153820487,4.025533547094786,0.004946562142052299,0.02488392767997796,0.016257004531602906,BICC1/SMAD2/SMAD3/CTNNB1,4
GO:0002011,morphogenesis of an epithelial sheet,3/81,56/13083,0.05357142857142857,8.652777777777779,4.529657972432776,0.005005585470992193,0.025129666897054304,0.01641754926621958,CCN1/JAG1/ITGB5,3
GO:0050680,negative regulation of epithelial cell proliferation,4/81,112/13083,0.03571428571428571,5.768518518518518,4.000186650800391,0.005105989219926342,0.025581730980158344,0.016712888809964948,DAB2/TGFB2/THBS1/STK3,4
GO:0002573,myeloid leukocyte differentiation,5/81,180/13083,0.027777777777777776,4.486625514403292,3.7176689037215644,0.005142688269592146,0.02571344134796073,0.01679893696416953,RUNX1/MYC/INHBA/CTNNB1/CREB1,5
GO:0043525,positive regulation of neuron apoptotic process,3/81,57/13083,0.05263157894736842,8.500974658869396,4.479443778766594,0.005260353615549611,0.026159027189306412,0.017090044185470585,TGFB2/GSK3B/CTNNB1,3
GO:2000027,regulation of animal organ morphogenesis,3/81,57/13083,0.05263157894736842,8.500974658869396,4.479443778766594,0.005260353615549611,0.026159027189306412,0.017090044185470585,FGF2/RUNX2/CTNNB1,3
GO:0052548,regulation of endopeptidase activity,5/81,181/13083,0.027624309392265192,4.46183752813587,3.701621007692951,0.005263577535662059,0.026159027189306412,0.017090044185470585,MYC/SERPINE1/THBS1/DLC1/SMAD3,5
GO:0003148,outflow tract septum morphogenesis,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,TGFB2/SMAD6,2
GO:0009065,glutamine family amino acid catabolic process,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,GLS/DDAH1,2
GO:0010566,regulation of ketone biosynthetic process,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,DAB2/CREB1,2
GO:0035929,steroid hormone secretion,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,DAB2/INHBA,2
GO:0036303,lymph vessel morphogenesis,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,PTPN14/FGF2,2
GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,FGF2/CTNNB1,2
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,FGF2/THBS1,2
GO:0045844,positive regulation of striated muscle tissue development,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,CTNNB1/CREB1,2
GO:0048636,positive regulation of muscle organ development,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,CTNNB1/CREB1,2
GO:0060392,negative regulation of SMAD protein signal transduction,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,SMAD7/SMAD6,2
GO:0072170,metanephric tubule development,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,WWTR1/YAP1,2
GO:0072243,metanephric nephron epithelium development,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,WWTR1/YAP1,2
GO:0090025,regulation of monocyte chemotaxis,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,SERPINE1/SLIT2,2
GO:1901863,positive regulation of muscle tissue development,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,CTNNB1/CREB1,2
GO:1904044,response to aldosterone,2/81,18/13083,0.1111111111111111,17.946502057613166,5.678532492940936,0.005431834544408133,0.026204358056031423,0.0171196594502008,INHBA/SGK1,2
GO:0030099,myeloid cell differentiation,7/81,345/13083,0.020289855072463767,3.2771873322597957,3.383235159445228,0.005459082570519961,0.02628447163583685,0.017171998729059404,RUNX1/ETS1/MYC/INHBA/JAG1/CTNNB1/CREB1,7
GO:0048705,skeletal system morphogenesis,5/81,183/13083,0.0273224043715847,4.413074276462254,3.6698721133319117,0.00551138500042044,0.02638554817896148,0.017238033393713166,CCN2/SMAD2/SMAD3/RUNX2/CTNNB1,5
GO:0046824,positive regulation of nucleocytoplasmic transport,3/81,58/13083,0.05172413793103448,8.3544061302682,4.430443891572686,0.005522805023693556,0.02638554817896148,0.017238033393713166,CDK1/SMAD3/GSK3B,3
GO:0051893,regulation of focal adhesion assembly,3/81,58/13083,0.05172413793103448,8.3544061302682,4.430443891572686,0.005522805023693556,0.02638554817896148,0.017238033393713166,THBS1/DLC1/SMAD3,3
GO:0090109,regulation of cell-substrate junction assembly,3/81,58/13083,0.05172413793103448,8.3544061302682,4.430443891572686,0.005522805023693556,0.02638554817896148,0.017238033393713166,THBS1/DLC1/SMAD3,3
GO:0007043,cell-cell junction assembly,4/81,115/13083,0.034782608695652174,5.618035426731079,3.9259447230223077,0.0056048931998016254,0.026726035141911225,0.01746047810464518,SMAD7/MPDZ/AMOT/CTNNB1,4
GO:0023061,signal release,7/81,347/13083,0.020172910662824207,3.2582986444657913,3.365147362111274,0.00563087585150601,0.026798195285587374,0.017507621296742146,DAB2/MYOF/INHBA/TGM2/SMAD2/EGFR/CREB1,7
GO:1902903,regulation of supramolecular fiber organization,7/81,348/13083,0.020114942528735632,3.2489357173265216,3.35615252889457,0.005718282901777233,0.027161843783441855,0.017745197749847164,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/AMOT,7
GO:0021987,cerebral cortex development,4/81,116/13083,0.034482758620689655,5.569604086845466,3.9017758321312175,0.005778176490040488,0.027254694553574745,0.01780585840640532,SLIT2/GSK3B/EGFR/CTNNB1,4
GO:0031016,pancreas development,3/81,59/13083,0.05084745762711865,8.21280602636535,4.3826073820571185,0.005793001878796251,0.027254694553574745,0.01780585840640532,SMAD2/GSK3B/CTNNB1,3
GO:0048844,artery morphogenesis,3/81,59/13083,0.05084745762711865,8.21280602636535,4.3826073820571185,0.005793001878796251,0.027254694553574745,0.01780585840640532,JAG1/TGFB2/SMAD7,3
GO:0072078,nephron tubule morphogenesis,3/81,59/13083,0.05084745762711865,8.21280602636535,4.3826073820571185,0.005793001878796251,0.027254694553574745,0.01780585840640532,MYC/FGF2/CTNNB1,3
GO:1903317,regulation of protein maturation,3/81,59/13083,0.05084745762711865,8.21280602636535,4.3826073820571185,0.005793001878796251,0.027254694553574745,0.01780585840640532,RUNX1/SERPINE1/THBS1,3
GO:0002521,leukocyte differentiation,8/81,442/13083,0.01809954751131222,2.9234120998826882,3.246887668872484,0.005935424981194451,0.027871672440209685,0.018208938355355402,RUNX1/MYC/INHBA/SMAD7/RUNX2/CTNNB1/CREB1/SMARCA2,8
GO:0031960,response to corticosteroid,4/81,117/13083,0.03418803418803419,5.522000633111745,3.8778860380676523,0.005955003921209718,0.02791054968764327,0.01823433738383002,INHBA/SLIT2/SGK1/EGFR,4
GO:0048588,developmental cell growth,5/81,187/13083,0.026737967914438502,4.318676965735789,3.6077195764871366,0.006031608154442733,0.02791611630351656,0.01823797412882629,SLIT2/SMAD7/USP9X/GSK3B/CTNNB1,5
GO:0003156,regulation of animal organ formation,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,FGF2/CTNNB1,2
GO:0007263,nitric oxide mediated signal transduction,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,DDAH1/THBS1,2
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,RUNX1/SMAD7,2
GO:0060561,apoptotic process involved in morphogenesis,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,CCN1/TGFB2,2
GO:0072207,metanephric epithelium development,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,WWTR1/YAP1,2
GO:0097320,plasma membrane tubulation,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,ASAP1/CAVIN2,2
GO:2000641,regulation of early endosome to late endosome transport,2/81,19/13083,0.10526315789473684,17.00194931773879,5.509169140793596,0.006046608187198931,0.02791611630351656,0.01823797412882629,NF2/DAB2,2
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/81,118/13083,0.03389830508474576,5.475204017576899,3.8542695415222004,0.006135406962469987,0.02827323730839714,0.01847128608300568,MYC/THBS1/DLC1/SMAD3,4
GO:0045860,positive regulation of protein kinase activity,5/81,189/13083,0.026455026455026454,4.272976680384088,3.577292739999254,0.006304303576069088,0.028997448478381094,0.018944422977778912,CCN1/TGFB2/FGF2/THBS1/EGFR,5
GO:0009064,glutamine family amino acid metabolic process,3/81,61/13083,0.04918032786885246,7.943533697632057,4.2902353847182235,0.006356870634057125,0.029076797159483518,0.01899626253803036,GLS/DDAH1/PHGDH,3
GO:0072028,nephron morphogenesis,3/81,61/13083,0.04918032786885246,7.943533697632057,4.2902353847182235,0.006356870634057125,0.029076797159483518,0.01899626253803036,MYC/FGF2/CTNNB1,3
GO:0072088,nephron epithelium morphogenesis,3/81,61/13083,0.04918032786885246,7.943533697632057,4.2902353847182235,0.006356870634057125,0.029076797159483518,0.01899626253803036,MYC/FGF2/CTNNB1,3
GO:0051336,regulation of hydrolase activity,8/81,448/13083,0.017857142857142856,2.884259259259259,3.2030708339826637,0.006423401047233797,0.029326803302527685,0.019159594912753014,ASAP1/MYC/SERPINE1/THBS1/DLC1/TGM2/SMAD3/GSK3B,8
GO:0003158,endothelium development,4/81,120/13083,0.03333333333333333,5.383950617283951,3.8078340839255387,0.006507064304244777,0.02958258805625188,0.01932670253152957,AMOTL2/JAG1/FSTL1/CTNNB1,4
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,4/81,120/13083,0.03333333333333333,5.383950617283951,3.8078340839255387,0.006507064304244777,0.02958258805625188,0.01932670253152957,DAB2/SMAD7/USP9X/GSK3B,4
GO:0007517,muscle organ development,6/81,270/13083,0.022222222222222223,3.589300411522634,3.39323087775532,0.006515355426154261,0.02958258805625188,0.01932670253152957,CENPF/TGFB2/SMAD7/SMAD3/CTNNB1/CREB1,6
GO:0051345,positive regulation of hydrolase activity,6/81,271/13083,0.02214022140221402,3.5760557605576055,3.3822518330975093,0.0066305851133738394,0.03005054170648327,0.01963242294312332,ASAP1/MYC/DLC1/TGM2/SMAD3/GSK3B,6
GO:0033135,regulation of peptidyl-serine phosphorylation,3/81,62/13083,0.04838709677419355,7.815412186379928,4.245612006099005,0.006650656953628387,0.030051420069199447,0.019632996789295868,GADD45A/SMAD7/EGFR,3
GO:0002053,positive regulation of mesenchymal cell proliferation,2/81,20/13083,0.1,16.151851851851855,5.352217463421293,0.006691611756299472,0.030051420069199447,0.019632996789295868,MYC/CTNNB1,2
GO:0003209,cardiac atrium morphogenesis,2/81,20/13083,0.1,16.151851851851855,5.352217463421293,0.006691611756299472,0.030051420069199447,0.019632996789295868,CCN1/TGFB2,2
GO:1901983,regulation of protein acetylation,2/81,20/13083,0.1,16.151851851851855,5.352217463421293,0.006691611756299472,0.030051420069199447,0.019632996789295868,TAOK1/GSK3B,2
GO:1902074,response to salt,2/81,20/13083,0.1,16.151851851851855,5.352217463421293,0.006691611756299472,0.030051420069199447,0.019632996789295868,DAB2/RUNX2,2
GO:0051054,positive regulation of DNA metabolic process,6/81,272/13083,0.022058823529411766,3.5629084967320264,3.371324357383008,0.006747293551239132,0.030246488333140933,0.01976043750893035,CDK1/MYC/FGF2/EGFR/CTNNB1/SMARCA2,6
GO:0061333,renal tubule morphogenesis,3/81,63/13083,0.047619047619047616,7.691358024691358,4.201975842239791,0.006952417612974938,0.030997240982036278,0.020250914308741368,MYC/FGF2/CTNNB1,3
GO:0071260,cellular response to mechanical stimulus,3/81,63/13083,0.047619047619047616,7.691358024691358,4.201975842239791,0.006952417612974938,0.030997240982036278,0.020250914308741368,GADD45A/FGF2/EGFR,3
GO:0150116,regulation of cell-substrate junction organization,3/81,63/13083,0.047619047619047616,7.691358024691358,4.201975842239791,0.006952417612974938,0.030997240982036278,0.020250914308741368,THBS1/DLC1/SMAD3,3
GO:0045862,positive regulation of proteolysis,6/81,274/13083,0.021897810218978103,3.5369018653690185,3.349622285871078,0.0069851896860579216,0.031087240584798316,0.020309712259320618,DAB2/MYC/DLC1/SMAD7/SMAD3/GSK3B,6
GO:0007292,female gamete generation,4/81,123/13083,0.032520325203252036,5.252634748569708,3.740095050366464,0.007092137341899175,0.03150643747210605,0.02058357922213449,INHBA/HEXB/USP9X/CTNNB1,4
GO:1903131,mononuclear cell differentiation,7/81,363/13083,0.01928374655647383,3.114682175288236,3.2249973526863305,0.007155476469920382,0.03173074843932378,0.020730124593003774,RUNX1/MYC/INHBA/SMAD7/RUNX2/CTNNB1/SMARCA2,7
GO:0035050,embryonic heart tube development,3/81,64/13083,0.046875,7.571180555555555,4.159288783372269,0.00726220501011373,0.03208881283538625,0.020964052877326715,SMAD3/CTNNB1/YAP1,3
GO:0071496,cellular response to external stimulus,3/81,64/13083,0.046875,7.571180555555555,4.159288783372269,0.00726220501011373,0.03208881283538625,0.020964052877326715,GADD45A/FGF2/EGFR,3
GO:0030194,positive regulation of blood coagulation,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,SERPINE1/THBS1,2
GO:0032874,positive regulation of stress-activated MAPK cascade,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,TGFB2/TAOK1,2
GO:0032925,regulation of activin receptor signaling pathway,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,SMAD7/SMAD6,2
GO:0035116,embryonic hindlimb morphogenesis,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,TP63/CTNNB1,2
GO:0060252,positive regulation of glial cell proliferation,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,ETV5/EGFR,2
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,TGFB2/TAOK1,2
GO:0070723,response to cholesterol,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,INHBA/SMAD2,2
GO:1900048,positive regulation of hemostasis,2/81,21/13083,0.09523809523809523,15.382716049382717,5.206192415233322,0.007366456846385281,0.03209020883698703,0.020964964903942514,SERPINE1/THBS1,2
GO:0071456,cellular response to hypoxia,4/81,125/13083,0.032,5.168592592592593,3.696153271315511,0.007500927290750083,0.03261846902843786,0.021310084389769973,MYC/INHBA/NDRG1/DDAH1,4
GO:0060560,developmental growth involved in morphogenesis,5/81,198/13083,0.025252525252525252,4.078750467639357,3.445397827103009,0.007639520877989401,0.033162770770885454,0.0216656840365512,SLIT2/USP9X/GSK3B/CTNNB1/YAP1,5
GO:0007163,establishment or maintenance of cell polarity,5/81,199/13083,0.02512562814070352,4.058254234133631,3.4312255473358424,0.007799136742729768,0.03373707137397991,0.022040882342344432,AMOTL2/AMOTL1/GSK3B/AMOT/FAT1,5
GO:0060326,cell chemotaxis,5/81,199/13083,0.02512562814070352,4.058254234133631,3.4312255473358424,0.007799136742729768,0.03373707137397991,0.022040882342344432,SERPINE1/TGFB2/FGF2/SLIT2/THBS1,5
GO:0009953,dorsal/ventral pattern formation,3/81,66/13083,0.045454545454545456,7.341750841750843,4.0766196315524645,0.007906060250543129,0.03404297370320911,0.022240732447057137,SMAD2/CTNNB1/SMAD6,3
GO:0035107,appendage morphogenesis,4/81,127/13083,0.031496062992125984,5.087197433654127,3.653141620865012,0.007924983756819935,0.03404297370320911,0.022240732447057137,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0035108,limb morphogenesis,4/81,127/13083,0.031496062992125984,5.087197433654127,3.653141620865012,0.007924983756819935,0.03404297370320911,0.022240732447057137,TGFB2/TP63/RUNX2/CTNNB1,4
GO:0051983,regulation of chromosome segregation,4/81,127/13083,0.031496062992125984,5.087197433654127,3.653141620865012,0.007924983756819935,0.03404297370320911,0.022240732447057137,CDK1/CENPF/RAD18/SMARCA2,4
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,FGF2/THBS1,2
GO:0002719,negative regulation of cytokine production involved in immune response,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,TGFB2/SMAD7,2
GO:0010714,positive regulation of collagen metabolic process,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,RUNX1/INHBA,2
GO:0030325,adrenal gland development,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,SMAD2/SMAD3,2
GO:0032967,positive regulation of collagen biosynthetic process,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,RUNX1/INHBA,2
GO:0035988,chondrocyte proliferation,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,CCN2/SMAD7,2
GO:0048333,mesodermal cell differentiation,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,INHBA/SMAD1,2
GO:0071542,dopaminergic neuron differentiation,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,GSK3B/CTNNB1,2
GO:1900745,positive regulation of p38MAPK cascade,2/81,22/13083,0.09090909090909091,14.683501683501685,5.069847273404985,0.008070758599165357,0.034134886540990464,0.022300780339799015,GADD45B/GADD45A,2
GO:0033674,positive regulation of kinase activity,5/81,201/13083,0.024875621890547265,4.017873594988023,3.4031565481980315,0.008125325029235471,0.034306927901216436,0.02241317727362659,CCN1/TGFB2/FGF2/THBS1/EGFR,5
GO:0070374,positive regulation of ERK1 and ERK2 cascade,4/81,128/13083,0.03125,5.047453703703703,3.6319734654188642,0.008142808642669043,0.034322077384628905,0.0224230746348332,CCN2/INHBA/FGF2/EGFR,4
GO:0033627,cell adhesion mediated by integrin,3/81,67/13083,0.04477611940298507,7.2321724709784405,4.036571002069842,0.008240223608370616,0.034614544749447994,0.022614147496656203,SERPINE1/TGFB2/ITGB5,3
GO:0055006,cardiac cell development,3/81,67/13083,0.04477611940298507,7.2321724709784405,4.036571002069842,0.008240223608370616,0.034614544749447994,0.022614147496656203,CDK1/INHBA/JAG1,3
GO:0042552,myelination,4/81,129/13083,0.031007751937984496,5.008326155612978,3.61102472767579,0.008364535578453208,0.03501763199793123,0.022877489815822962,PMP22/NDRG1/HEXB/CTNNB1,4
GO:1903034,regulation of response to wounding,4/81,129/13083,0.031007751937984496,5.008326155612978,3.61102472767579,0.008364535578453208,0.03501763199793123,0.022877489815822962,SERPINE1/FGF2/THBS1/SMAD3,4
GO:0051493,regulation of cytoskeleton organization,8/81,470/13083,0.01702127659574468,2.749251379038613,3.048361423402717,0.008478315662533684,0.035433908098914044,0.02314944858965917,NF2/CCN2/SLIT2/DLC1/TAOK1/SMAD3/GSK3B/AMOT,8
GO:0001570,vasculogenesis,3/81,68/13083,0.04411764705882353,7.125816993464053,3.9973381588359436,0.008582604784295301,0.03580917874528614,0.023394617948657,AMOT/CTNNB1/YAP1,3
GO:0046639,negative regulation of alpha-beta T cell differentiation,2/81,23/13083,0.08695652173913043,14.045088566827697,4.942126556823695,0.008804135675233324,0.036368818255261705,0.023760237965189085,RUNX1/SMAD7,2
GO:0060441,epithelial tube branching involved in lung morphogenesis,2/81,23/13083,0.08695652173913043,14.045088566827697,4.942126556823695,0.008804135675233324,0.036368818255261705,0.023760237965189085,CTNNB1/YAP1,2
GO:1905207,regulation of cardiocyte differentiation,2/81,23/13083,0.08695652173913043,14.045088566827697,4.942126556823695,0.008804135675233324,0.036368818255261705,0.023760237965189085,TGFB2/EGFR,2
GO:0050821,protein stabilization,5/81,205/13083,0.024390243902439025,3.9394760614272815,3.3480901935823018,0.008805990168665652,0.036368818255261705,0.023760237965189085,SMAD7/SMAD3/USP9X/CREB1/STK3,5
GO:0051222,positive regulation of protein transport,5/81,205/13083,0.024390243902439025,3.9394760614272815,3.3480901935823018,0.008805990168665652,0.036368818255261705,0.023760237965189085,CDK1/TGFB2/SMAD3/GSK3B/EGFR,5
GO:0007272,ensheathment of neurons,4/81,131/13083,0.030534351145038167,4.931863160870794,3.5697690985037895,0.00881980653234889,0.036368818255261705,0.023760237965189085,PMP22/NDRG1/HEXB/CTNNB1,4
GO:0008366,axon ensheathment,4/81,131/13083,0.030534351145038167,4.931863160870794,3.5697690985037895,0.00881980653234889,0.036368818255261705,0.023760237965189085,PMP22/NDRG1/HEXB/CTNNB1,4
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,5/81,206/13083,0.024271844660194174,3.920352391226178,3.33454070384888,0.008982145344958847,0.03697649833674725,0.0241572435330209,TGFB2/FGF2/THBS1/EGFR/STK3,5
GO:0036294,cellular response to decreased oxygen levels,4/81,132/13083,0.030303030303030304,4.894500561167227,3.5494542733950074,0.009053405212773384,0.03720783839525833,0.024308381103742182,MYC/INHBA/NDRG1/DDAH1,4
GO:0001894,tissue homeostasis,5/81,207/13083,0.024154589371980676,3.9014134907854716,3.3210760122680996,0.009160728487985437,0.037524045381963564,0.02451496337973584,CCN2/EGFR/CTNNB1/WWTR1/YAP1,5
GO:0060249,anatomical structure homeostasis,5/81,207/13083,0.024154589371980676,3.9014134907854716,3.3210760122680996,0.009160728487985437,0.037524045381963564,0.02451496337973584,CCN2/EGFR/CTNNB1/WWTR1/YAP1,5
GO:0033157,regulation of intracellular protein transport,4/81,133/13083,0.03007518796992481,4.857699805068226,3.529342991355488,0.009291015263750039,0.03781172001071952,0.02470290508264778,PTPN14/CDK1/SMAD3/GSK3B,4
GO:0001892,embryonic placenta development,3/81,70/13083,0.04285714285714286,6.9222222222222225,3.921204620278327,0.00929219192166265,0.03781172001071952,0.02470290508264778,CCN1/EGFR/STK3,3
GO:0071621,granulocyte chemotaxis,3/81,70/13083,0.04285714285714286,6.9222222222222225,3.921204620278327,0.00929219192166265,0.03781172001071952,0.02470290508264778,TGFB2/SLIT2/THBS1,3
GO:1902017,regulation of cilium assembly,3/81,70/13083,0.04285714285714286,6.9222222222222225,3.921204620278327,0.00929219192166265,0.03781172001071952,0.02470290508264778,ASAP1/GSK3B/YAP1,3
GO:0001945,lymph vessel development,2/81,24/13083,0.08333333333333333,13.459876543209877,4.822129841716814,0.00956621022612462,0.03873531025988166,0.025306299010610944,PTPN14/FGF2,2
GO:0031128,developmental induction,2/81,24/13083,0.08333333333333333,13.459876543209877,4.822129841716814,0.00956621022612462,0.03873531025988166,0.025306299010610944,FGF2/CTNNB1,2
GO:0044346,fibroblast apoptotic process,2/81,24/13083,0.08333333333333333,13.459876543209877,4.822129841716814,0.00956621022612462,0.03873531025988166,0.025306299010610944,MYC/TP63,2
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,3/81,71/13083,0.04225352112676056,6.824726134585289,3.8842498592865042,0.009659479199286494,0.03904895846520072,0.02551120960032078,LATS2/GADD45A/EGFR,3
GO:0030902,hindbrain development,4/81,135/13083,0.02962962962962963,4.785733882030178,3.489716298979753,0.009778375222280207,0.03940063099352709,0.025740961991509503,FGF2/DLC1/CTNNB1/SMAD1,4
GO:0048771,tissue remodeling,4/81,135/13083,0.02962962962962963,4.785733882030178,3.489716298979753,0.009778375222280207,0.03940063099352709,0.025740961991509503,RUNX1/JAG1/EGFR/CTNNB1,4
GO:0030098,lymphocyte differentiation,6/81,295/13083,0.020338983050847456,3.285122410546139,3.1332400176424486,0.009864290219610498,0.039682079547944504,0.02592483611634304,RUNX1/INHBA/SMAD7/RUNX2/CTNNB1/SMARCA2,6
GO:0071900,regulation of protein serine/threonine kinase activity,5/81,211/13083,0.023696682464454975,3.827453045462524,3.2680456513693796,0.009899660759591823,0.03975961313201919,0.025975489849301266,LATS2/GADD45A/FGF2/THBS1/EGFR,5
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/81,72/13083,0.041666666666666664,6.729938271604938,3.8480025762069503,0.010035146976481965,0.040173116745397815,0.026245637319708016,DAB2/SMAD7/GSK3B,3
GO:0046889,positive regulation of lipid biosynthetic process,3/81,72/13083,0.041666666666666664,6.729938271604938,3.8480025762069503,0.010035146976481965,0.040173116745397815,0.026245637319708016,DAB2/CCN1/CREB1,3
GO:0007548,sex differentiation,5/81,212/13083,0.02358490566037736,3.809399021663173,3.25499040832029,0.01009062302212379,0.040329836350559485,0.02634802434494255,INHBA/TGFB2/SLIT2/TP63/CTNNB1,5
GO:2000116,regulation of cysteine-type endopeptidase activity,4/81,137/13083,0.029197080291970802,4.715869153825358,3.450860441714152,0.010282094603251173,0.04079875826227689,0.026654377334783926,MYC/THBS1/DLC1/SMAD3,4
GO:0009954,proximal/distal pattern formation,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,TP63/CTNNB1,2
GO:0010092,specification of animal organ identity,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,FGF2/CTNNB1,2
GO:0010955,negative regulation of protein processing,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,SERPINE1/THBS1,2
GO:0035767,endothelial cell chemotaxis,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,FGF2/THBS1,2
GO:0036314,response to sterol,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,INHBA/SMAD2,2
GO:0044060,regulation of endocrine process,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,DAB2/INHBA,2
GO:0050820,positive regulation of coagulation,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,SERPINE1/THBS1,2
GO:1901889,negative regulation of cell junction assembly,2/81,25/13083,0.08,12.921481481481482,4.709083612746054,0.01035660786657798,0.04079875826227689,0.026654377334783926,THBS1/DLC1,2
GO:0048661,positive regulation of smooth muscle cell proliferation,3/81,73/13083,0.0410958904109589,6.6377473363774735,3.812438891389113,0.010419231671956951,0.04091494790100742,0.026730285588001015,FGF2/THBS1/EGFR,3
GO:0060021,roof of mouth development,3/81,73/13083,0.0410958904109589,6.6377473363774735,3.812438891389113,0.010419231671956951,0.04091494790100742,0.026730285588001015,INHBA/TGFB2/SMAD2,3
GO:0022408,negative regulation of cell-cell adhesion,4/81,138/13083,0.028985507246376812,4.681696188942565,3.4317130383588554,0.010540152688215197,0.041324090698240536,0.0269975840785863,RUNX1/NF2/JAG1/SMAD7,4
GO:0090596,sensory organ morphogenesis,5/81,215/13083,0.023255813953488372,3.7562446167097328,3.2162956504098017,0.010678710407681079,0.04180097417903687,0.02730913846855467,JAG1/FJX1/FGF2/FAT1/CTNNB1,5
GO:1904029,regulation of cyclin-dependent protein kinase activity,3/81,74/13083,0.04054054054054054,6.548048048048048,3.777536049583768,0.01081176805196523,0.04225485298790209,0.02760566359703981,LATS2/GADD45A/EGFR,3
GO:1990138,neuron projection extension,4/81,140/13083,0.02857142857142857,4.614814814814815,3.393962947567254,0.011068789945117093,0.043191012898008245,0.02821726945350379,SLIT2/USP9X/GSK3B/CTNNB1,4
GO:0006541,glutamine metabolic process,2/81,26/13083,0.07692307692307693,12.424501424501425,4.6023191217648725,0.011174957647000277,0.04326355076503242,0.028264659417342724,GLS/PHGDH,2
GO:0110110,positive regulation of animal organ morphogenesis,2/81,26/13083,0.07692307692307693,12.424501424501425,4.6023191217648725,0.011174957647000277,0.04326355076503242,0.028264659417342724,FGF2/CTNNB1,2
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/81,26/13083,0.07692307692307693,12.424501424501425,4.6023191217648725,0.011174957647000277,0.04326355076503242,0.028264659417342724,SERPINE1/GSK3B,2
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2/81,26/13083,0.07692307692307693,12.424501424501425,4.6023191217648725,0.011174957647000277,0.04326355076503242,0.028264659417342724,FGF2/CTNNB1,2
GO:1903318,negative regulation of protein maturation,2/81,26/13083,0.07692307692307693,12.424501424501425,4.6023191217648725,0.011174957647000277,0.04326355076503242,0.028264659417342724,SERPINE1/THBS1,2
GO:0018107,peptidyl-threonine phosphorylation,3/81,75/13083,0.04,6.460740740740741,3.743272352549086,0.011212789253966023,0.04327435852702512,0.02827172027356894,CDK1/SMAD7/GSK3B,3
GO:1903510,mucopolysaccharide metabolic process,3/81,75/13083,0.04,6.460740740740741,3.743272352549086,0.011212789253966023,0.04327435852702512,0.02827172027356894,FGF2/HMMR/HEXB,3
GO:0030595,leukocyte chemotaxis,4/81,141/13083,0.028368794326241134,4.582085631731022,3.3753539674530795,0.011339417826971574,0.043694792562589374,0.02854639548197294,SERPINE1/TGFB2/SLIT2/THBS1,4
GO:0048562,embryonic organ morphogenesis,5/81,219/13083,0.0228310502283105,3.6876374090985964,3.165768985624914,0.01149886943866651,0.04410280669799112,0.028812956602608308,SMAD2/SMAD3/RUNX2/CTNNB1/YAP1,5
GO:0052547,regulation of peptidase activity,5/81,219/13083,0.0228310502283105,3.6876374090985964,3.165768985624914,0.01149886943866651,0.04410280669799112,0.028812956602608308,MYC/SERPINE1/THBS1/DLC1/SMAD3,5
GO:1903532,positive regulation of secretion by cell,5/81,219/13083,0.0228310502283105,3.6876374090985964,3.165768985624914,0.01149886943866651,0.04410280669799112,0.028812956602608308,DAB2/INHBA/TGFB2/EGFR/CREB1,5
GO:0034329,cell junction assembly,7/81,400/13083,0.0175,2.8265740740740743,2.9284026387123667,0.011835821381180035,0.045324773351185565,0.029611283847162786,THBS1/DLC1/SMAD7/SMAD3/MPDZ/AMOT/CTNNB1,7
GO:0045664,regulation of neuron differentiation,4/81,143/13083,0.027972027972027972,4.518000518000518,3.3386529787814516,0.011893411333730706,0.04546953032855751,0.0297058555268181,JAG1/FGF2/ETV5/GSK3B,4
GO:0002701,negative regulation of production of molecular mediator of immune response,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,TGFB2/SMAD7,2
GO:0010464,regulation of mesenchymal cell proliferation,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,MYC/CTNNB1,2
GO:0021983,pituitary gland development,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,FGF2/CREB1,2
GO:0030279,negative regulation of ossification,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,SMAD7/SMAD6,2
GO:0045648,positive regulation of erythrocyte differentiation,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,ETS1/INHBA,2
GO:0060317,cardiac epithelial to mesenchymal transition,2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,JAG1/TGFB2,2
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",2/81,27/13083,0.07407407407407407,11.964334705075446,4.50125479496463,0.012020892026132815,0.04546953032855751,0.0297058555268181,RUNX1/SMAD7,2
GO:0030217,T cell differentiation,5/81,222/13083,0.02252252252252252,3.637804471137804,3.128644507172261,0.0121415501015143,0.04585570145373138,0.029958146315180144,RUNX1/SMAD7/RUNX2/CTNNB1/SMARCA2,5
GO:0071453,cellular response to oxygen levels,4/81,144/13083,0.027777777777777776,4.486625514403292,3.320555125713749,0.012176823632817906,0.045918708966504164,0.029999309970445722,MYC/INHBA/NDRG1/DDAH1,4
GO:0048041,focal adhesion assembly,3/81,78/13083,0.038461538461538464,6.212250712250713,3.6441137208611516,0.012467069224447383,0.0467988768759651,0.030574335500044538,THBS1/DLC1/SMAD3,3
GO:0048145,regulation of fibroblast proliferation,3/81,78/13083,0.038461538461538464,6.212250712250713,3.6441137208611516,0.012467069224447383,0.0467988768759651,0.030574335500044538,MYC/EGFR/CTNNB1,3
GO:0051262,protein tetramerization,3/81,78/13083,0.038461538461538464,6.212250712250713,3.6441137208611516,0.012467069224447383,0.0467988768759651,0.030574335500044538,GLS/TP63/STK3,3
GO:0001709,cell fate determination,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,JAG1/CTNNB1,2
GO:0002548,monocyte chemotaxis,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,SERPINE1/SLIT2,2
GO:0003230,cardiac atrium development,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,CCN1/TGFB2,2
GO:0030513,positive regulation of BMP signaling pathway,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,CCN1/SMAD2,2
GO:0032965,regulation of collagen biosynthetic process,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,RUNX1/INHBA,2
GO:0035137,hindlimb morphogenesis,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,TP63/CTNNB1,2
GO:0055010,ventricular cardiac muscle tissue morphogenesis,2/81,28/13083,0.07142857142857142,11.537037037037036,4.405382123494517,0.01289404684391796,0.047892173991695285,0.03128860120573999,TGFB2/SMAD7,2
GO:0046879,hormone secretion,5/81,226/13083,0.022123893805309734,3.5734185512946572,3.0801319806165743,0.013035965247857322,0.048337180020134395,0.03157932962747327,DAB2/INHBA/SMAD2/EGFR/CREB1,5
GO:0097529,myeloid leukocyte migration,4/81,147/13083,0.027210884353741496,4.395061728395062,3.2672385139198674,0.013052995576287304,0.048337180020134395,0.03157932962747327,SERPINE1/TGFB2/SLIT2/THBS1,4
GO:2000177,regulation of neural precursor cell proliferation,3/81,80/13083,0.0375,6.056944444444444,3.5808480763431154,0.01334621631803845,0.04934903339154936,0.032240387039951066,NF2/FGF2/CTNNB1,3
GO:1901990,regulation of mitotic cell cycle phase transition,6/81,316/13083,0.0189873417721519,3.066807313642757,2.9354426691631157,0.0135070248651202,0.049868985675406416,0.032580078858043066,CDK1/CENPF/INHBA/TAOK1/EGFR/SMARCA2,6
